Michael P. Lisanti - Publications

Affiliations: 
2006- Yeshiva University, New York, NY, United States 
 2009- Thomas Jefferson University 
 2012- University of Salford, UK 
Area:
Metabolism, Breast Cancer, Cell Biology, Stem Cells, Drug Discovery
Website:
https://www.salford.ac.uk/environment-life-sciences/our-staff/els-academics/michael-lisanti

398 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 De Francesco EM, Ózsvári B, Sotgia F, Lisanti MP. Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine). Frontiers in Oncology. 9: 615. PMID 31440463 DOI: 10.3389/fonc.2019.00615  0.6
2019 Peiris-Pagès M, Ozsvári B, Sotgia F, Lisanti MP. Mitochondrial and ribosomal biogenesis are new hallmarks of stemness, oncometabolism and biomass accumulation in cancer: Mito-stemness and ribo-stemness features. Aging. PMID 31311889 DOI: 10.18632/aging.102054  0.6
2019 Fiorillo M, Tóth F, Sotgia F, Lisanti MP. Doxycycline, Azithromycin and Vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs). Aging. PMID 31002656 DOI: 10.18632/aging.101905  0.6
2019 Sotgia F, Fiorillo M, Lisanti MP. Hallmarks of the cancer cell of origin: Comparisons with "energetic" cancer stem cells (e-CSCs). Aging. 11: 1065-1068. PMID 30760648 DOI: 10.18632/aging.101822  0.6
2018 Fiorillo M, Sotgia F, Lisanti MP. "Energetic" Cancer Stem Cells (e-CSCs): A New Hyper-Metabolic and Proliferative Tumor Cell Phenotype, Driven by Mitochondrial Energy. Frontiers in Oncology. 8: 677. PMID 30805301 DOI: 10.3389/fonc.2018.00677  0.6
2018 Fiorillo M, Sanchez-Alvarez R, Sotgia F, Lisanti MP. The ER-alpha mutation Y537S confers Tamoxifen-resistance via enhanced mitochondrial metabolism, glycolysis and Rho-GDI/PTEN signaling: Implicating TIGAR in somatic resistance to endocrine therapy. Aging. 10: 4000-4023. PMID 30573703 DOI: 10.18632/aging.101690  0.6
2018 Ozsvari B, Nuttall JR, Sotgia F, Lisanti MP. Azithromycin and Roxithromycin define a new family of "senolytic" drugs that target senescent human fibroblasts. Aging. PMID 30428454 DOI: 10.18632/aging.101633  0.6
2018 Scatena C, Roncella M, Di Paolo A, Aretini P, Menicagli M, Fanelli G, Marini C, Mazzanti CM, Ghilli M, Sotgia F, Lisanti MP, Naccarato AG. Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study. Frontiers in Oncology. 8: 452. PMID 30364293 DOI: 10.3389/fonc.2018.00452  0.6
2018 Sotgia F, Ozsvari B, Fiorillo M, De Francesco EM, Bonuccelli G, Lisanti MP. A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX. Cell Cycle (Georgetown, Tex.). 1-10. PMID 30257595 DOI: 10.1080/15384101.2018.1515551  0.6
2018 Bonuccelli G, Sotgia F, Lisanti MP. Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways. Aging. 10: 1867-1883. PMID 30153655 DOI: 10.18632/aging.101483  0.6
2018 De Francesco EM, Sotgia F, Lisanti MP. Cancer stem cells (CSCs): metabolic strategies for their identification and eradication. The Biochemical Journal. 475: 1611-1634. PMID 29743249 DOI: 10.1042/BCJ20170164  0.6
2018 Fiorillo M, Peiris-Pagès M, Sanchez-Alvarez R, Bartella L, Di Donna L, Dolce V, Sindona G, Sotgia F, Cappello AR, Lisanti MP. Bergamot natural products eradicate cancer stem cells (CSCs) by targeting mevalonate, Rho-GDI-signalling and mitochondrial metabolism. Biochimica Et Biophysica Acta. PMID 29626418 DOI: 10.1016/j.bbabio.2018.03.018  0.6
2018 Peiris-Pagès M, Bonuccelli G, Sotgia F, Lisanti MP. Mitochondrial fission as a driver of stemness in tumor cells: mDIVI1 inhibits mitochondrial function, cell migration and cancer stem cell (CSC) signalling. Oncotarget. 9: 13254-13275. PMID 29568355 DOI: 10.18632/oncotarget.24285  0.6
2018 Ozsvari B, Sotgia F, Lisanti MP. Exploiting mitochondrial targeting signal(s), TPP and bis-TPP, for eradicating cancer stem cells (CSCs). Aging. PMID 29466249 DOI: 10.18632/aging.101384  0.6
2017 Ozsvari B, Bonuccelli G, Sanchez-Alvarez R, Foster R, Sotgia F, Lisanti MP. Targeting flavin-containing enzymes eliminates cancer stem cells (CSCs), by inhibiting mitochondrial respiration: Vitamin B2 (Riboflavin) in cancer therapy. Aging. PMID 29253841 DOI: 10.18632/aging.101351  0.6
2017 Monti D, Sotgia F, Whitaker-Menezes D, Tuluc M, Birbe R, Berger A, Lazar M, Cotzia P, Draganova-Tacheva R, Lin Z, Domingo-Vidal M, Newberg A, Lisanti MP, Martinez-Outschoorn U. Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in Breast Cancer. Seminars in Oncology. 44: 226-232. PMID 29248134 DOI: 10.1053/j.seminoncol.2017.10.001  0.6
2017 Mikkilineni L, Whitaker-Menezes D, Domingo-Vidal M, Sprandio J, Avena P, Cotzia P, Dulau-Florea A, Gong J, Uppal G, Zhan T, Leiby B, Lin Z, Pro B, Sotgia F, Lisanti MP, et al. Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment. Seminars in Oncology. 44: 218-225. PMID 29248133 DOI: 10.1053/j.seminoncol.2017.10.003  0.6
2017 De Francesco EM, Sotgia F, Clarke RB, Lisanti MP, Maggiolini M. G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts. International Journal of Molecular Sciences. 18. PMID 29240722 DOI: 10.3390/ijms18122713  0.6
2017 De Francesco EM, Sims AH, Maggiolini M, Sotgia F, Lisanti MP, Clarke RB. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment. Breast Cancer Research : Bcr. 19: 129. PMID 29212519 DOI: 10.1186/s13058-017-0923-5  0.6
2017 Pestell TG, Jiao X, Kumar M, Peck AR, Prisco M, Deng S, Li Z, Ertel A, Casimiro MC, Ju X, Di Rocco A, Di Sante G, Katiyar S, Shupp A, Lisanti MP, et al. Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth. Oncotarget. 8: 81754-81775. PMID 29137220 DOI: 10.18632/oncotarget.19953  0.72
2017 Ozsvari B, Sotgia F, Simmons K, Trowbridge R, Foster R, Lisanti MP. Mitoketoscins: Novel mitochondrial inhibitors for targeting ketone metabolism in cancer stem cells (CSCs). Oncotarget. 8: 78340-78350. PMID 29108233 DOI: 10.18632/oncotarget.21259  0.6
2017 Ozsvari B, Sotgia F, Lisanti MP. A new mutation-independent approach to cancer therapy: Inhibiting oncogenic RAS and MYC, by targeting mitochondrial biogenesis. Aging. PMID 29080556 DOI: 10.18632/aging.101304  0.56
2017 Sotgia F, Fiorillo M, Lisanti MP. Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics. Oncotarget. 8: 68730-68745. PMID 28978152 DOI: 10.18632/oncotarget.19612  0.6
2017 Sotgia F, Lisanti MP. Mitochondrial markers predict survival and progression in non-small cell lung cancer (NSCLC) patients: Use as companion diagnostics. Oncotarget. 8: 68095-68107. PMID 28978099 DOI: 10.18632/oncotarget.19677  0.6
2017 Ozsvari B, Fiorillo M, Bonuccelli G, Cappello AR, Frattaruolo L, Sotgia F, Trowbridge R, Foster R, Lisanti MP. Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast. Oncotarget. 8: 67457-67472. PMID 28978045 DOI: 10.18632/oncotarget.19084  0.6
2017 De Francesco EM, Bonuccelli G, Maggiolini M, Sotgia F, Lisanti MP. Vitamin C and Doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs). Oncotarget. 8: 67269-67286. PMID 28978032 DOI: 10.18632/oncotarget.18428  0.6
2017 Sotgia F, Lisanti MP. Mitochondrial biomarkers predict tumor progression and poor overall survival in gastric cancers: Companion diagnostics for personalized medicine. Oncotarget. 8: 67117-67128. PMID 28978020 DOI: 10.18632/oncotarget.19962  0.6
2017 Sotgia F, Lisanti MP. Mitochondrial mRNA transcripts predict overall survival, tumor recurrence and progression in serous ovarian cancer: Companion diagnostics for cancer therapy. Oncotarget. 8: 66925-66939. PMID 28978006 DOI: 10.18632/oncotarget.19963  0.6
2017 De Francesco EM, Maggiolini M, Tanowitz HB, Sotgia F, Lisanti MP. Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy. Oncotarget. 8: 56126-56142. PMID 28915578 DOI: 10.18632/oncotarget.18445  0.6
2017 Sotgia F, Lisanti MP. Mitochondrial markers predict survival and progression in non-small cell lung cancer (NSCLC) patients: Use as companion diagnostics. Oncotarget. PMID 28767386 DOI: 10.18632/oncotarget.19677  0.6
2017 Sotgia F, Fiorillo M, Lisanti MP. Mitochondrial markers predict recurrence, metastasis and Tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics. Oncotarget. PMID 28754844 DOI: 10.18632/oncotarget.19612  0.6
2017 Ozsvari B, Fiorillo M, Bonuccelli G, Cappello AR, Frattaruolo L, Sotgia F, Trowbridge R, Foster R, Lisanti MP. Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast. Oncotarget. PMID 28696944 DOI: 10.18632/oncotarget.19084  0.6
2017 De Francesco EM, Maggiolini M, Tanowitz HB, Sotgia F, Lisanti MP. Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: implications for optimizing anti-angiogenic therapy. Oncotarget. PMID 28632134 DOI: 10.18632/oncotarget.18445  0.6
2017 De Francesco EM, Bonuccelli G, Maggiolini M, Sotgia F, Lisanti MP. Vitamin C and Doxycycline: a synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs). Oncotarget. PMID 28622697 DOI: 10.18632/oncotarget.18428  0.6
2017 Fiorillo M, Sotgia F, Sisci D, Cappello AR, Lisanti MP. Mitochondrial "power" drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer. Oncotarget. 8: 20309-20327. PMID 28411284 DOI: 10.18632/oncotarget.15852  0.6
2017 Guazzelli A, Bakker E, Krstic-Demonacos M, Lisanti MP, Sotgia F, Mutti L. Anti-CTLA-4 therapy for malignant mesothelioma. Immunotherapy. 9: 273-280. PMID 28231719 DOI: 10.2217/imt-2016-0123  0.6
2017 Bonuccelli G, De Francesco EM, de Boer R, Tanowitz HB, Lisanti MP. NADH autofluorescence, a new metabolic biomarker for cancer stem cells: Identification of Vitamin C and CAPE as natural products targeting "stemness". Oncotarget. PMID 28223550 DOI: 10.18632/oncotarget.15400  0.52
2017 Martinez-Outschoorn UE, Peiris-Pagés M, Pestell RG, Sotgia F, Lisanti MP. Cancer metabolism: a therapeutic perspective. Nature Reviews. Clinical Oncology. PMID 28094266 DOI: 10.1038/nrclinonc.2017.1  0.72
2016 Bonuccelli G, Peiris-Pages M, Ozsvari B, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity. Oncotarget. PMID 28039467 DOI: 10.18632/oncotarget.14196  0.6
2016 Ju X, Jiao X, Ertel A, Casimiro MC, Di Sante G, Deng S, Li Z, Di Rocco A, Zhan T, Hawkins A, Stoyanova T, Ando S, Fatatis A, Lisanti MP, Gomella LG, et al. SRC ONCOGENE INDUCES TROP2 PROTEOLYTIC ACTIVATION VIA CYCLIN D1. Cancer Research. PMID 27634768 DOI: 10.1158/0008-5472.CAN-15-3327  0.72
2016 Fiorillo M, Lamb R, Tanowitz HB, Cappello AR, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs). Aging. PMID 27344270  0.6
2016 Peiris-Pagès M, Martinez-Outschoorn UE, Pestell RG, Sotgia F, Lisanti MP. Cancer stem cell metabolism. Breast Cancer Research : Bcr. 18: 55. PMID 27220421 DOI: 10.1186/s13058-016-0712-6  1
2016 Martinez-Outschoorn UE, Peiris-Pagés M, Pestell RG, Sotgia F, Lisanti MP. Cancer metabolism: a therapeutic perspective. Nature Reviews. Clinical Oncology. PMID 27141887 DOI: 10.1038/nrclinonc.2016.60  0.72
2016 Fiorillo M, Lamb R, Tanowitz HB, Mutti L, Krstic-Demonacos M, Cappello AR, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells. Oncotarget. PMID 27136895 DOI: 10.18632/oncotarget.9122  1
2016 Johnson SM, Dempsey C, Chadwick A, Harrison S, Liu J, Di Y, McGinn OJ, Fiorillo M, Sotgia F, Lisanti M, Parihar M, Krishnan S, Saha V. Metabolic reprogramming of bone marrow stromal cells by leukemic extracellular vesicles in acute lymphoblastic leukemia. Blood. PMID 27099150 DOI: 10.1182/blood-2015-12-688051  0.6
2015 Gutierrez-Pajares JL, Iturrieta J, Dulam V, Wang Y, Pavlides S, Malacari G, Lisanti MP, Frank PG. Caveolin-3 Promotes a Vascular Smooth Muscle Contractile Phenotype. Frontiers in Cardiovascular Medicine. 2: 27. PMID 26664898 DOI: 10.3389/fcvm.2015.00027  0.92
2015 Peiris-Pagès M, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Metastasis and Oxidative Stress: Are Antioxidants a Metabolic Driver of Progression? Cell Metabolism. 22: 956-8. PMID 26636492 DOI: 10.1016/j.cmet.2015.11.008  1
2015 Casimiro MC, Di Sante G, Ju X, Li Z, Chen K, Crosariol M, Yaman I, Gormley M, Meng H, Lisanti MP, Pestell RG. Cyclin D1 promotes androgen-dependent DNA damage repair in prostate cancer cells. Cancer Research. PMID 26582866 DOI: 10.1158/0008-5472.CAN-15-0999  0.72
2015 Peiris-Pagès M, Smith DL, Győrffy B, Sotgia F, Lisanti MP. Proteomic identification of prognostic tumour biomarkers, using chemotherapy-induced cancer-associated fibroblasts. Aging. 7: 816-38. PMID 26539730  0.6
2015 Peiris-Pagès M, Sotgia F, Lisanti MP. Doxycycline and therapeutic targeting of the DNA damage response in cancer cells: old drug, new purpose. Oncoscience. 2: 696-9. PMID 26425660 DOI: 10.18632/oncoscience.215  1
2015 Lamb R, Bonuccelli G, Ozsvári B, Peiris-Pagès M, Fiorillo M, Smith DL, Bevilacqua G, Mazzanti CM, McDonnell LA, Naccarato AG, Chiu M, Wynne L, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling. Oncotarget. 6: 30453-71. PMID 26421711 DOI: 10.18632/oncotarget.5852  1
2015 Farnie G, Sotgia F, Lisanti MP. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant. Oncotarget. 6: 30472-86. PMID 26421710 DOI: 10.18632/oncotarget.5401  1
2015 Lamb R, Ozsvari B, Bonuccelli G, Smith DL, Pestell RG, Martinez-Outschoorn UE, Clarke RB, Sotgia F, Lisanti MP. Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells. Oncotarget. 6: 21892-905. PMID 26323205  0.72
2015 Casaburi I, Avena P, De Luca A, Chimento A, Sirianni R, Malivindi R, Rago V, Fiorillo M, Domanico F, Campana C, Cappello AR, Sotgia F, Lisanti MP, Pezzi V. Estrogen related receptor α (ERRα) a promising target for the therapy of adrenocortical carcinoma (ACC). Oncotarget. 6: 25135-48. PMID 26312764 DOI: 10.18632/oncotarget.4722  1
2015 Chi Y, Jasmin JF, Seki Y, Lisanti MP, Charron MJ, Lefer DJ, Schuster VL. Inhibition of the Prostaglandin Transporter PGT Lowers Blood Pressure in Hypertensive Rats and Mice. Plos One. 10: e0131735. PMID 26121580 DOI: 10.1371/journal.pone.0131735  0.6
2015 De Luca A, Fiorillo M, Peiris-Pagès M, Ozsvari B, Smith DL, Sanchez-Alvarez R, Martinez-Outschoorn UE, Cappello AR, Pezzi V, Lisanti MP, Sotgia F. Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells. Oncotarget. PMID 26087310  1
2015 Lamb R, Fiorillo M, Chadwick A, Ozsvari B, Reeves KJ, Smith DL, Clarke RB, Howell SJ, Cappello AR, Martinez-Outschoorn UE, Peiris-Pagès M, Sotgia F, Lisanti MP. Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy. Oncotarget. 6: 14005-25. PMID 26087309  1
2015 Ward R, Sims AH, Lee A, Lo C, Wynne L, Yusuf H, Gregson H, Lisanti MP, Sotgia F, Landberg G, Lamb R. Monocytes and macrophages, implications for breast cancer migration and stem cell-like activity and treatment. Oncotarget. 6: 14687-99. PMID 26008983  1
2015 Casimiro MC, Di Sante G, Crosariol M, Loro E, Dampier W, Ertel A, Yu Z, Saria EA, Papanikolaou A, Li Z, Wang C, Addya S, Lisanti MP, Fortina P, Cardiff RD, et al. Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis. Oncotarget. 6: 8525-38. PMID 25940700  1
2015 Peiris-Pagès M, Sotgia F, Lisanti MP. Chemotherapy induces the cancer-associated fibroblast phenotype, activating paracrine Hedgehog-GLI signalling in breast cancer cells. Oncotarget. 6: 10728-45. PMID 25915429 DOI: 10.18632/oncotarget.3828  0.6
2015 Brojatsch J, Lima H, Palliser D, Jacobson LS, Muehlbauer SM, Furtado R, Goldman DL, Lisanti MP, Chandran K. Distinct cathepsins control necrotic cell death mediated by pyroptosis inducers and lysosome-destabilizing agents. Cell Cycle (Georgetown, Tex.). 14: 964-72. PMID 25830414 DOI: 10.4161/15384101.2014.991194  1
2015 Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Caveolae and signalling in cancer. Nature Reviews. Cancer. 15: 225-37. PMID 25801618 DOI: 10.1038/nrc3915  1
2015 Chen K, Wu K, Jiao X, Wang L, Ju X, Wang M, Di Sante G, Xu S, Wang Q, Li K, Sun X, Xu C, Li Z, Casimiro MC, Ertel A, ... ... Lisanti MP, et al. The Endogenous Cell-Fate Factor Dachshund Restrains Prostate Epithelial Cell Migration via Repression of Cytokine Secretion via a CXCL Signaling Module. Cancer Research. 75: 1992-2004. PMID 25769723 DOI: 10.1158/0008-5472.CAN-14-0611  0.72
2015 Fiorillo M, Verre AF, Iliut M, Peiris-Pagés M, Ozsvari B, Gandara R, Cappello AR, Sotgia F, Vijayaraghavan A, Lisanti MP. Graphene oxide selectively targets cancer stem cells, across multiple tumor types: implications for non-toxic cancer treatment, via "differentiation-based nano-therapy". Oncotarget. 6: 3553-62. PMID 25708684 DOI: 10.18632/oncotarget.3348  1
2015 Lamb R, Harrison H, Smith DL, Townsend PA, Jackson T, Ozsvari B, Martinez-Outschoorn UE, Pestell RG, Howell A, Lisanti MP, Sotgia F. Targeting tumor-initiating cells: eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction. Oncotarget. 6: 4585-601. PMID 25671304  1
2015 Lamb R, Ozsvari B, Lisanti CL, Tanowitz HB, Howell A, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease. Oncotarget. 6: 4569-84. PMID 25625193  1
2015 Di Sante G, Pestell TG, Casimiro MC, Bisetto S, Powell MJ, Lisanti MP, Cordon-Cardo C, Castillo-Martin M, Bonal DM, Debattisti V, Chen K, Wang L, He X, McBurney MW, Pestell RG. Loss of Sirt1 promotes prostatic intraepithelial neoplasia, reduces mitophagy, and delays PARK2 translocation to mitochondria. The American Journal of Pathology. 185: 266-79. PMID 25529796 DOI: 10.1016/j.ajpath.2014.09.014  1
2014 Sotgia F, Martinez-Outschoorn UE, Lisanti MP. The reverse Warburg effect in osteosarcoma. Oncotarget. 5: 7982-3. PMID 25478627 DOI: 10.18632/oncotarget.2352  1
2014 Sicoli D, Jiao X, Ju X, Velasco-Velazquez M, Ertel A, Addya S, Li Z, Andò S, Fatatis A, Paudyal B, Cristofanilli M, Thakur ML, Lisanti MP, Pestell RG. CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines. Cancer Research. 74: 7103-14. PMID 25452256 DOI: 10.1158/0008-5472.CAN-14-0612  1
2014 Lamb R, Harrison H, Hulit J, Smith DL, Lisanti MP, Sotgia F. Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition. Oncotarget. 5: 11029-37. PMID 25415228  1
2014 Pavlides S, Gutierrez-Pajares JL, Katiyar S, Jasmin JF, Mercier I, Walters R, Pavlides C, Pestell RG, Lisanti MP, Frank PG. Caveolin-1 regulates the anti-atherogenic properties of macrophages. Cell and Tissue Research. 358: 821-31. PMID 25322709 DOI: 10.1007/s00441-014-2008-4  0.92
2014 Lamb R, Lisanti MP, Clarke RB, Landberg G. Co-ordination of cell cycle, migration and stem cell-like activity in breast cancer. Oncotarget. 5: 7833-42. PMID 25277201  1
2014 Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Metabolic asymmetry in cancer: a "balancing act" that promotes tumor growth. Cancer Cell. 26: 5-7. PMID 25026205 DOI: 10.1016/j.ccr.2014.06.021  1
2014 Wright PK, Jones SB, Ardern N, Ward R, Clarke RB, Sotgia F, Lisanti MP, Landberg G, Lamb R. 17β-estradiol regulates giant vesicle formation via estrogen receptor-alpha in human breast cancer cells. Oncotarget. 5: 3055-65. PMID 24931391  1
2014 Li Z, Chen K, Jiao X, Wang C, Willmarth NE, Casimiro MC, Li W, Ju X, Kim SH, Lisanti MP, Katzenellenbogen JA, Pestell RG. Cyclin D1 integrates estrogen-mediated DNA damage repair signaling. Cancer Research. 74: 3959-70. PMID 24830723 DOI: 10.1158/0008-5472.CAN-13-3137  1
2014 Martinez-Outschoorn U, Sotgia F, Lisanti MP. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function. Seminars in Oncology. 41: 195-216. PMID 24787293 DOI: 10.1053/j.seminoncol.2014.03.002  1
2014 Martinez-Outschoorn UE, Lisanti MP. Tumor microenvironment: introduction. Seminars in Oncology. 41: 145. PMID 24787288 DOI: 10.1053/j.seminoncol.2014.03.007  1
2014 Mercier I, Gonzales DM, Quann K, Pestell TG, Molchansky A, Sotgia F, Hulit J, Gandara R, Wang C, Pestell RG, Lisanti MP, Jasmin JF. CAPER, a novel regulator of human breast cancer progression. Cell Cycle (Georgetown, Tex.). 13: 1256-64. PMID 24621503 DOI: 10.4161/cc.28156  0.76
2014 Martinez-Outschoorn UE, Lisanti MP, Sotgia F. Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth. Seminars in Cancer Biology. 25: 47-60. PMID 24486645 DOI: 10.1016/j.semcancer.2014.01.005  1
2014 Lisanti MP, Tsirigos A, Pavlides S, Reeves KJ, Peiris-Pagès M, Chadwick AL, Sanchez-Alvarez R, Lamb R, Howell A, Martinez-Outschoorn UE, Sotgia F. JNK1 stress signaling is hyper-activated in high breast density and the tumor stroma: connecting fibrosis, inflammation, and stemness for cancer prevention. Cell Cycle (Georgetown, Tex.). 13: 580-99. PMID 24434780 DOI: 10.4161/cc.27379  1
2014 Bassan P, Mellor J, Shapiro J, Williams KJ, Lisanti MP, Gardner P. Transmission FT-IR chemical imaging on glass substrates: applications in infrared spectral histopathology. Analytical Chemistry. 86: 1648-53. PMID 24410403 DOI: 10.1021/ac403412n  1
2014 Pavlides S, Gutierrez-Pajares JL, Iturrieta J, Lisanti MP, Frank PG. Endothelial caveolin-1 plays a major role in the development of atherosclerosis Cell and Tissue Research. 356: 147-157. PMID 24390341 DOI: 10.1007/s00441-013-1767-7  1
2014 Wu K, Chen K, Wang C, Jiao X, Wang L, Zhou J, Wang J, Li Z, Addya S, Sorensen PH, Lisanti MP, Quong A, Ertel A, Pestell RG. Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation. Cancer Research. 74: 829-39. PMID 24335958 DOI: 10.1158/0008-5472.CAN-13-2466  1
2014 Ju X, Casimiro MC, Gormley M, Meng H, Jiao X, Katiyar S, Crosariol M, Chen K, Wang M, Quong AA, Lisanti MP, Ertel A, Pestell RG. Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint. Cancer Research. 74: 508-19. PMID 24282282 DOI: 10.1158/0008-5472.CAN-13-1313  1
2013 De Almeida CJG, Jasmin JF, Del Galdo F, Lisanti MP. Genetic ablation of caveolin-2 sensitizes mice to bleomycin-induced injury Cell Cycle. 12: 2248-2254. PMID 24067367 DOI: 10.4161/cc.25335  1
2013 Danilo C, Gutierrez-Pajares JL, Mainieri MA, Mercier I, Lisanti MP, Frank PG. Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development Breast Cancer Research. 15. PMID 24060386 DOI: 10.1186/bcr3483  1
2013 Lisanti MP, Sotgia F, Pestell RG, Howell A, Martinez-Outschoorn UE. Stromal glycolysis and MCT4 are hallmarks of DCIS progression to invasive breast cancer. Cell Cycle (Georgetown, Tex.). 12: 2935-6. PMID 23989616 DOI: 10.4161/cc.26280  1
2013 Martinez-Outschoorn UE, Whitaker-Menezes D, Valsecchi M, Martinez-Cantarin MP, Dulau-Florea A, Gong J, Howell A, Flomenberg N, Pestell RG, Wagner J, Arana-Yi C, Sharma M, Sotgia F, Lisanti MP. Reverse Warburg effect in a patient with aggressive B-cell lymphoma: is lactic acidosis a paraneoplastic syndrome? Seminars in Oncology. 40: 403-18. PMID 23972703 DOI: 10.1053/j.seminoncol.2013.04.016  1
2013 Chadwick AL, Howell A, Sotgia F, Lisanti MP. Carbonic anhydrase 9 (CA9) and redox signaling in cancer-associated fibroblasts: therapeutic implications. Cell Cycle (Georgetown, Tex.). 12: 2534-5. PMID 23907127 DOI: 10.4161/cc.25842  1
2013 Sotgia F, Martinez-Outschoorn UE, Lisanti MP. Cancer metabolism: new validated targets for drug discovery. Oncotarget. 4: 1309-16. PMID 23896568 DOI: 10.18632/oncotarget.1182  1
2013 Casimiro MC, Wang C, Li Z, Di Sante G, Willmart NE, Addya S, Chen L, Liu Y, Lisanti MP, Pestell RG. Cyclin D1 determines estrogen signaling in the mammary gland in vivo. Molecular Endocrinology (Baltimore, Md.). 27: 1415-28. PMID 23864650 DOI: 10.1210/me.2013-1065  1
2013 Lisanti MP, Martinez-Outschoorn UE, Sotgia F. Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discovery. Cell Cycle (Georgetown, Tex.). 12: 2723-32. PMID 23860382 DOI: 10.4161/cc.25695  1
2013 Martinez-Outschoorn UE, Curry JM, Ko YH, Lin Z, Tuluc M, Cognetti D, Birbe RC, Pribitkin E, Bombonati A, Pestell RG, Howell A, Sotgia F, Lisanti MP. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4. Cell Cycle (Georgetown, Tex.). 12: 2580-97. PMID 23860378 DOI: 10.4161/cc.25510  1
2013 Chen K, Wu K, Gormley M, Ertel A, Wang J, Zhang W, Zhou J, Disante G, Li Z, Rui H, Quong AA, McMahon SB, Deng H, Lisanti MP, Wang C, et al. Acetylation of the cell-fate factor dachshund determines p53 binding and signaling modules in breast cancer. Oncotarget. 4: 923-35. PMID 23798621  1
2013 Ayala G, Morello M, Frolov A, You S, Li R, Rosati F, Bartolucci G, Danza G, Adam RM, Thompson TC, Lisanti MP, Freeman MR, Di Vizio D. Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression. The Journal of Pathology. 231: 77-87. PMID 23729330 DOI: 10.1002/path.4217  1
2013 Lima H, Jacobson LS, Goldberg MF, Chandran K, Diaz-Griffero F, Lisanti MP, Brojatsch J. Role of lysosome rupture in controlling Nlrp3 signaling and necrotic cell death. Cell Cycle (Georgetown, Tex.). 12: 1868-78. PMID 23708522 DOI: 10.4161/cc.24903  1
2013 Saleh AD, Simone BA, Palazzo J, Savage JE, Sano Y, Dan T, Jin L, Champ CE, Zhao S, Lim M, Sotgia F, Camphausen K, Pestell RG, Mitchell JB, Lisanti MP, et al. Caloric restriction augments radiation efficacy in breast cancer. Cell Cycle (Georgetown, Tex.). 12: 1955-63. PMID 23708519 DOI: 10.4161/cc.25016  1
2013 Volonte D, Liu Z, Musille PM, Stoppani E, Wakabayashi N, Di YP, Lisanti MP, Kensler TW, Galbiati F. Inhibition of nuclear factor-erythroid 2-related factor (Nrf2) by caveolin-1 promotes stress-induced premature senescence. Molecular Biology of the Cell. 24: 1852-62. PMID 23637463 DOI: 10.1091/mbc.E12-09-0666  1
2013 Quann K, Gonzales DM, Mercier I, Wang C, Sotgia F, Pestell RG, Lisanti MP, Jasmin JF. Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide Cell Cycle. 12: 1510-1520. PMID 23598719 DOI: 10.4161/cc.24497  1
2013 Araujo KP, Bonuccelli G, Duarte CN, Gaiad TP, Moreira DF, Feder D, Belizario JE, Miglino MA, Lisanti MP, Ambrosio CE. Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin-glycoprotein complex in GRMD dogs. Plos One. 8: e61367. PMID 23579193 DOI: 10.1371/journal.pone.0061367  1
2013 Curry JM, Tuluc M, Whitaker-Menezes D, Ames JA, Anantharaman A, Butera A, Leiby B, Cognetti DM, Sotgia F, Lisanti MP, Martinez-Outschoorn UE. Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer. Cell Cycle (Georgetown, Tex.). 12: 1371-84. PMID 23574725 DOI: 10.4161/cc.24092  1
2013 Avena P, Anselmo W, Whitaker-Menezes D, Wang C, Pestell RG, Lamb RS, Hulit J, Casaburi I, Andò S, Martinez-Outschoorn UE, Lisanti MP, Sotgia F. Compartment-specific activation of PPARγ governs breast cancer tumor growth, via metabolic reprogramming and symbiosis. Cell Cycle (Georgetown, Tex.). 12: 1360-70. PMID 23574724 DOI: 10.4161/cc.24289  1
2013 Chen K, Wu K, Cai S, Zhang W, Zhou J, Wang J, Ertel A, Li Z, Rui H, Quong A, Lisanti MP, Tozeren A, Tanes C, Addya S, Gormley M, et al. Dachshund binds p53 to block the growth of lung adenocarcinoma cells. Cancer Research. 73: 3262-74. PMID 23492369 DOI: 10.1158/0008-5472.CAN-12-3191  1
2013 Mukherjee S, Sadekar N, Ashton AW, Huang H, Spray DC, Lisanti MP, Machado FS, Weiss LM, Tanowitz HB. Identification of a functional prostanoid-like receptor in the protozoan parasite, Trypanosoma cruzi. Parasitology Research. 112: 1417-25. PMID 23403991 DOI: 10.1007/s00436-012-3271-5  1
2013 Trimmer C, Sotgia F, Lisanti MP, Capozza F. Cav1 inhibits benign skin tumor development in a two-stage carcinogenesis model by suppressing epidermal proliferation. American Journal of Translational Research. 5: 80-91. PMID 23390568  0.56
2013 Salem AF, Al-Zoubi MS, Whitaker-Menezes D, Martinez-Outschoorn UE, Lamb R, Hulit J, Howell A, Gandara R, Sartini M, Galbiati F, Bevilacqua G, Sotgia F, Lisanti MP. Cigarette smoke metabolically promotes cancer, via autophagy and premature aging in the host stromal microenvironment. Cell Cycle (Georgetown, Tex.). 12: 818-25. PMID 23388463 DOI: 10.4161/cc.23722  1
2013 Nagajyothi F, Kuliawat R, Kusminski CM, Machado FS, Desruisseaux MS, Zhao D, Schwartz GJ, Huang H, Albanese C, Lisanti MP, Singh R, Li F, Weiss LM, Factor SM, Pessin JE, et al. Alterations in glucose homeostasis in a murine model of Chagas disease. The American Journal of Pathology. 182: 886-94. PMID 23321322 DOI: 10.1016/j.ajpath.2012.11.027  1
2013 Champ CE, Baserga R, Mishra MV, Jin L, Sotgia F, Lisanti MP, Pestell RG, Dicker AP, Simone NL. Nutrient restriction and radiation therapy for cancer treatment: when less is more. The Oncologist. 18: 97-103. PMID 23299773 DOI: 10.1634/theoncologist.2012-0164  1
2013 Al-Zoubi M, Salem AF, Martinez-Outschoorn UE, Whitaker-Menezes D, Lamb R, Hulit J, Howell A, Gandara R, Sartini M, Arafat H, Bevilacqua G, Sotgia F, Lisanti MP. Creating a tumor-resistant microenvironment: cell-mediated delivery of TNFα completely prevents breast cancer tumor formation in vivo. Cell Cycle (Georgetown, Tex.). 12: 480-90. PMID 23292149 DOI: 10.4161/cc.23370  1
2013 Trimmer C, Bonuccelli G, Katiyar S, Sotgia F, Pestell RG, Lisanti MP, Capozza F. Cav1 suppresses tumor growth and metastasis in a murine model of cutaneous SCC through modulation of MAPK/AP-1 activation. The American Journal of Pathology. 182: 992-1004. PMID 23267770 DOI: 10.1016/j.ajpath.2012.11.008  1
2013 Suk HY, Zhou C, Yang TT, Zhu H, Yu RY, Olabisi O, Yang X, Brancho D, Kim JY, Scherer PE, Frank PG, Lisanti MP, Calvert JW, Lefer DJ, Molkentin JD, et al. Ablation of calcineurin Aβ reveals hyperlipidemia and signaling cross-talks with phosphodiesterases. The Journal of Biological Chemistry. 288: 3477-88. PMID 23258544 DOI: 10.1074/jbc.M112.419150  1
2013 Sanchez-Alvarez R, Martinez-Outschoorn UE, Lin Z, Lamb R, Hulit J, Howell A, Sotgia F, Rubin E, Lisanti MP. Ethanol exposure induces the cancer-associated fibroblast phenotype and lethal tumor metabolism: implications for breast cancer prevention. Cell Cycle (Georgetown, Tex.). 12: 289-301. PMID 23257780 DOI: 10.4161/cc.23109  1
2013 Sanchez-Alvarez R, Martinez-Outschoorn UE, Lamb R, Hulit J, Howell A, Gandara R, Sartini M, Rubin E, Lisanti MP, Sotgia F. Mitochondrial dysfunction in breast cancer cells prevents tumor growth: understanding chemoprevention with metformin. Cell Cycle (Georgetown, Tex.). 12: 172-82. PMID 23257779 DOI: 10.4161/cc.23058  1
2013 Ju X, Ertel A, Casimiro MC, Yu Z, Meng H, McCue PA, Walters R, Fortina P, Lisanti MP, Pestell RG. Novel oncogene-induced metastatic prostate cancer cell lines define human prostate cancer progression signatures. Cancer Research. 73: 978-89. PMID 23204233 DOI: 10.1158/0008-5472.CAN-12-2133  1
2013 Jelicks LA, Lisanti MP, Machado FS, Weiss LM, Tanowitz HB, Desruisseaux MS. Imaging of small-animal models of infectious diseases. The American Journal of Pathology. 182: 296-304. PMID 23201133 DOI: 10.1016/j.ajpath.2012.09.026  1
2013 Li Z, Wermuth PJ, Benn BS, Lisanti MP, Jimenez SA. Caveolin-1 deficiency induces spontaneous endothelial-to-mesenchymal transition in murine pulmonary endothelial cells in vitro. The American Journal of Pathology. 182: 325-31. PMID 23195429 DOI: 10.1016/j.ajpath.2012.10.022  1
2012 Sotgia F, Martinez-Outschoorn UE, Lisanti MP. Genetic induction of the Warburg effect inhibits tumor growth. Oncotarget. 3: 1266-7. PMID 23175502 DOI: 10.18632/oncotarget.739  1
2012 Martinez-Outschoorn UE, Balliet R, Lin Z, Whitaker-Menezes D, Birbe RC, Bombonati A, Pavlides S, Lamb R, Sneddon S, Howell A, Sotgia F, Lisanti MP. BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment: implications for breast cancer prevention with antioxidant therapies. Cell Cycle (Georgetown, Tex.). 11: 4402-13. PMID 23172369 DOI: 10.4161/cc.22776  1
2012 Sotgia F, Whitaker-Menezes D, Martinez-Outschoorn UE, Salem AF, Tsirigos A, Lamb R, Sneddon S, Hulit J, Howell A, Lisanti MP. Mitochondria "fuel" breast cancer metabolism: fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cells. Cell Cycle (Georgetown, Tex.). 11: 4390-401. PMID 23172368 DOI: 10.4161/cc.22777  1
2012 Martinez-Outschoorn UE, Lin Z, Whitaker-Menezes D, Howell A, Sotgia F, Lisanti MP. Ketone body utilization drives tumor growth and metastasis. Cell Cycle (Georgetown, Tex.). 11: 3964-71. PMID 23082722 DOI: 10.4161/cc.22137  1
2012 Martinez-Outschoorn UE, Lin Z, Whitaker-Menezes D, Howell A, Lisanti MP, Sotgia F. Ketone bodies and two-compartment tumor metabolism: stromal ketone production fuels mitochondrial biogenesis in epithelial cancer cells. Cell Cycle (Georgetown, Tex.). 11: 3956-63. PMID 23082721 DOI: 10.4161/cc.22136  1
2012 Salem AF, Whitaker-Menezes D, Howell A, Sotgia F, Lisanti MP. Mitochondrial biogenesis in epithelial cancer cells promotes breast cancer tumor growth and confers autophagy resistance. Cell Cycle (Georgetown, Tex.). 11: 4174-80. PMID 23070475 DOI: 10.4161/cc.22376  1
2012 Martinez-Outschoorn UE, Balliet RM, Lin Z, Whitaker-Menezes D, Howell A, Sotgia F, Lisanti MP. Hereditary ovarian cancer and two-compartment tumor metabolism: epithelial loss of BRCA1 induces hydrogen peroxide production, driving oxidative stress and NFκB activation in the tumor stroma. Cell Cycle (Georgetown, Tex.). 11: 4152-66. PMID 23047606 DOI: 10.4161/cc.22226  1
2012 Salem AF, Howell A, Sartini M, Sotgia F, Lisanti MP. Downregulation of stromal BRCA1 drives breast cancer tumor growth via upregulation of HIF-1α, autophagy and ketone body production. Cell Cycle (Georgetown, Tex.). 11: 4167-73. PMID 23047605 DOI: 10.4161/cc.22316  1
2012 Bonuccelli G, Castello-Cros R, Capozza F, Martinez-Outschoorn UE, Lin Z, Tsirigos A, Xuanmao J, Whitaker-Menezes D, Howell A, Lisanti MP, Sotgia F. The milk protein α-casein functions as a tumor suppressor via activation of STAT1 signaling, effectively preventing breast cancer tumor growth and metastasis. Cell Cycle (Georgetown, Tex.). 11: 3972-82. PMID 23047602 DOI: 10.4161/cc.22227  1
2012 Di Vizio D, Morello M, Dudley AC, Schow PW, Adam RM, Morley S, Mulholland D, Rotinen M, Hager MH, Insabato L, Moses MA, Demichelis F, Lisanti MP, Wu H, Klagsbrun M, et al. Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. The American Journal of Pathology. 181: 1573-84. PMID 23022210 DOI: 10.1016/j.ajpath.2012.07.030  1
2012 Shikani HJ, Freeman BD, Lisanti MP, Weiss LM, Tanowitz HB, Desruisseaux MS. Cerebral malaria: we have come a long way. The American Journal of Pathology. 181: 1484-92. PMID 23021981 DOI: 10.1016/j.ajpath.2012.08.010  1
2012 Sirajuddin P, Das S, Ringer L, Rodriguez OC, Sivakumar A, Lee YC, Üren A, Fricke ST, Rood B, Ozcan A, Wang SS, Karam S, Yenugonda V, Salinas P, Petricoin E, ... ... Lisanti MP, et al. Quantifying the CDK inhibitor VMY-1-103's activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI. Cell Cycle (Georgetown, Tex.). 11: 3801-9. PMID 22983062 DOI: 10.4161/cc.21988  1
2012 Yu Z, Pestell TG, Lisanti MP, Pestell RG. Cancer stem cells. The International Journal of Biochemistry & Cell Biology. 44: 2144-51. PMID 22981632 DOI: 10.1016/j.biocel.2012.08.022  1
2012 Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, Ahn HJ, Ait-Mohamed O, Ait-Si-Ali S, Akematsu T, Akira S, ... ... Lisanti MP, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 8: 445-544. PMID 22966490  0.4
2012 Capparelli C, Chiavarina B, Whitaker-Menezes D, Pestell TG, Pestell RG, Hulit J, Andò S, Howell A, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, "fueling" tumor growth via paracrine interactions, without an increase in neo-angiogenesis. Cell Cycle (Georgetown, Tex.). 11: 3599-610. PMID 22935696 DOI: 10.4161/cc.21884  1
2012 Carito V, Bonuccelli G, Martinez-Outschoorn UE, Whitaker-Menezes D, Caroleo MC, Cione E, Howell A, Pestell RG, Lisanti MP, Sotgia F. Metabolic remodeling of the tumor microenvironment: migration stimulating factor (MSF) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth. Cell Cycle (Georgetown, Tex.). 11: 3403-14. PMID 22918248 DOI: 10.4161/cc.21701  1
2012 Chiavarina B, Martinez-Outschoorn UE, Whitaker-Menezes D, Howell A, Tanowitz HB, Pestell RG, Sotgia F, Lisanti MP. Metabolic reprogramming and two-compartment tumor metabolism: opposing role(s) of HIF1α and HIF2α in tumor-associated fibroblasts and human breast cancer cells. Cell Cycle (Georgetown, Tex.). 11: 3280-9. PMID 22894905 DOI: 10.4161/cc.21643  1
2012 Guido C, Whitaker-Menezes D, Lin Z, Pestell RG, Howell A, Zimmers TA, Casimiro MC, Aquila S, Ando' S, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth. Oncotarget. 3: 798-810. PMID 22878233 DOI: 10.18632/oncotarget.574  1
2012 Guido C, Whitaker-Menezes D, Capparelli C, Balliet R, Lin Z, Pestell RG, Howell A, Aquila S, Andò S, Martinez-Outschoorn U, Sotgia F, Lisanti MP. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production. Cell Cycle (Georgetown, Tex.). 11: 3019-35. PMID 22874531 DOI: 10.4161/cc.21384  1
2012 Guido C, Panza S, Santoro M, Avena P, Panno ML, Perrotta I, Giordano F, Casaburi I, Catalano S, De Amicis F, Sotgia F, Lisanti MP, Andò S, Aquila S. Estrogen receptor beta (ERβ) produces autophagy and necroptosis in human seminoma cell line through the binding of the Sp1 on the phosphatase and tensin homolog deleted from chromosome 10 (PTEN) promoter gene. Cell Cycle (Georgetown, Tex.). 11: 2911-21. PMID 22810004 DOI: 10.4161/cc.21336  1
2012 Salem AF, Whitaker-Menezes D, Lin Z, Martinez-Outschoorn UE, Tanowitz HB, Al-Zoubi MS, Howell A, Pestell RG, Sotgia F, Lisanti MP. Two-compartment tumor metabolism: autophagy in the tumor microenvironment and oxidative mitochondrial metabolism (OXPHOS) in cancer cells. Cell Cycle (Georgetown, Tex.). 11: 2545-56. PMID 22722266 DOI: 10.4161/cc.20920  1
2012 Mercier I, Camacho J, Titchen K, Gonzales DM, Quann K, Bryant KG, Molchansky A, Milliman JN, Whitaker-Menezes D, Sotgia F, Jasmin JF, Schwarting R, Pestell RG, Blagosklonny MV, Lisanti MP. Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug. The American Journal of Pathology. 181: 278-93. PMID 22698676 DOI: 10.1016/j.ajpath.2012.03.017  1
2012 Capparelli C, Whitaker-Menezes D, Guido C, Balliet R, Pestell TG, Howell A, Sneddon S, Pestell RG, Martinez-Outschoorn U, Lisanti MP, Sotgia F. CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth. Cell Cycle (Georgetown, Tex.). 11: 2272-84. PMID 22684333 DOI: 10.4161/cc.20717  1
2012 Capparelli C, Guido C, Whitaker-Menezes D, Bonuccelli G, Balliet R, Pestell TG, Goldberg AF, Pestell RG, Howell A, Sneddon S, Birbe R, Tsirigos A, Martinez-Outschoorn U, Sotgia F, Lisanti MP. Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production. Cell Cycle (Georgetown, Tex.). 11: 2285-302. PMID 22684298 DOI: 10.4161/cc.20718  1
2012 Esper L, Roman-Campos D, Lara A, Brant F, Castro LL, Barroso A, Araujo RR, Vieira LQ, Mukherjee S, Gomes ER, Rocha NN, Ramos IP, Lisanti MP, Campos CF, Arantes RM, et al. Role of SOCS2 in modulating heart damage and function in a murine model of acute Chagas disease. The American Journal of Pathology. 181: 130-40. PMID 22658486 DOI: 10.1016/j.ajpath.2012.03.042  1
2012 Velasco-Velázquez M, Jiao X, De La Fuente M, Pestell TG, Ertel A, Lisanti MP, Pestell RG. CCR5 antagonist blocks metastasis of basal breast cancer cells. Cancer Research. 72: 3839-50. PMID 22637726 DOI: 10.1158/0008-5472.CAN-11-3917  1
2012 Gazzerro E, Baldassari S, Giacomini C, Musante V, Fruscione F, La Padula V, Biancheri R, Scarfì S, Prada V, Sotgia F, Duncan ID, Zara F, Werner HB, Lisanti MP, Nobbio L, et al. Hyccin, the molecule mutated in the leukodystrophy hypomyelination and congenital cataract (HCC), is a neuronal protein. Plos One. 7: e32180. PMID 22461884 DOI: 10.1371/journal.pone.0032180  1
2012 Lisanti MP, Tanowitz HB. Translational discoveries, personalized medicine, and living biobanks of the future. The American Journal of Pathology. 180: 1334-6. PMID 22453029 DOI: 10.1016/j.ajpath.2012.02.003  1
2012 Pavlides S, Gutierrez-Pajares JL, Danilo C, Lisanti MP, Frank PG. Atherosclerosis, caveolae and caveolin-1. Advances in Experimental Medicine and Biology. 729: 127-44. PMID 22411318 DOI: 10.1007/978-1-4614-1222-9_9  1
2012 Mercier I, Lisanti MP. Caveolin-1 and breast cancer: a new clinical perspective. Advances in Experimental Medicine and Biology. 729: 83-94. PMID 22411315 DOI: 10.1007/978-1-4614-1222-9_6  1
2012 Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Power surge: Supporting cells "fuel" cancer cell mitochondria Cell Metabolism. 15: 4-5. DOI: 10.1016/j.cmet.2011.12.011  1
2012 Jasmin JF, Frank PG, Lisanti MP. Preface Advances in Experimental Medicine and Biology. 729: v-vi.  1
2011 Freeman MR, Kim J, Lisanti MP, Di Vizio D. A metabolic perturbation by U0126 identifies a role for glutamine in resveratrol-induced cell death. Cancer Biology & Therapy. 12: 966-77. PMID 22108021 DOI: 10.4161/cbt.12.11.18136  1
2011 Huang H, Ma YF, Bao Y, Lee H, Lisanti MP, Tanowitz HB, Weiss LM. Molecular cloning and characterization of mitogen-activated protein kinase 2 in Toxoplasma gondii. Cell Cycle (Georgetown, Tex.). 10: 3519-26. PMID 22030559 DOI: 10.4161/cc.10.20.17791  1
2011 Sotgia F, Martinez-Outschoorn UE, Pavlides S, Howell A, Pestell RG, Lisanti MP. Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment. Breast Cancer Research : Bcr. 13: 213. PMID 21867571 DOI: 10.1186/bcr2892  1
2011 Ren G, Jacob RF, Kaulin Y, Dimuzio P, Xie Y, Mason RP, Tint GS, Steiner RD, Roullet JB, Merkens L, Whitaker-Menezes D, Frank PG, Lisanti MP, Cox RH, Tulenko TN. Alterations in membrane caveolae and BKCa channel activity in skin fibroblasts in Smith-Lemli-Opitz syndrome. Molecular Genetics and Metabolism. 104: 346-55. PMID 21724437 DOI: 10.1016/j.ymgme.2011.04.019  1
2011 de Almeida CJ, Witkiewicz AK, Jasmin JF, Tanowitz HB, Sotgia F, Frank PG, Lisanti MP. Caveolin-2-deficient mice show increased sensitivity to endotoxemia. Cell Cycle (Georgetown, Tex.). 10: 2151-61. PMID 21670588 DOI: 10.4161/cc.10.13.16234  1
2011 Velasco-Velázquez MA, Popov VM, Lisanti MP, Pestell RG. The role of breast cancer stem cells in metastasis and therapeutic implications. The American Journal of Pathology. 179: 2-11. PMID 21640330 DOI: 10.1016/j.ajpath.2011.03.005  1
2011 Sotgia F, Martinez-Outschoorn UE, Lisanti MP. Mitochondrial oxidative stress drives tumor progression and metastasis: Should we use antioxidants as a key component of cancer treatment and prevention? Bmc Medicine. 9. PMID 21605374 DOI: 10.1186/1741-7015-9-62  1
2011 Martinez-Outschoorn UE, Pavlides S, Sotgia F, Lisanti MP. Mitochondrial biogenesis drives tumor cell proliferation American Journal of Pathology. 178: 1949-1952. PMID 21514412 DOI: 10.1016/j.ajpath.2011.03.002  1
2011 Janowski E, Jiao X, Katiyar S, Lisanti MP, Liu M, Pestell RG, Morad M. c-Jun is required for TGF-β-mediated cellular migration via nuclear Ca²⁺ signaling. The International Journal of Biochemistry & Cell Biology. 43: 1104-13. PMID 21447400 DOI: 10.1016/j.biocel.2011.03.011  1
2011 Crist RC, Roth JJ, Lisanti MP, Siracusa LD, Buchberg AM. Identification of Mom12 and Mom13, two novel modifier loci of Apc (Min) -mediated intestinal tumorigenesis. Cell Cycle (Georgetown, Tex.). 10: 1092-9. PMID 21386660 DOI: 10.4161/cc.10.7.15089  1
2011 Thomas NM, Jasmin JF, Lisanti MP, Iacobas DA. Sex differences in expression and subcellular localization of heart rhythm determinant proteins Biochemical and Biophysical Research Communications. 406: 117-122. PMID 21296051 DOI: 10.1016/j.bbrc.2011.02.006  1
2011 Wang C, Tai Y, Lisanti MP, Liao DJ. c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis. Cancer Biology & Therapy. 11: 615-26. PMID 21278493 DOI: 10.4161/cbt.11.7.14688  1
2011 Llaverias G, Danilo C, Mercier I, Daumer K, Capozza F, Williams TM, Sotgia F, Lisanti MP, Frank PG. Role of cholesterol in the development and progression of breast cancer. The American Journal of Pathology. 178: 402-12. PMID 21224077 DOI: 10.1016/j.ajpath.2010.11.005  1
2011 Wang C, Lisanti MP, Liao DJ. Reviewing once more the c-myc and Ras collaboration: Converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology Cell Cycle. 10: 57-67. PMID 21200143 DOI: 10.4161/cc.10.1.14449  1
2010 Llaverias G, Danilo C, Wang Y, Witkiewicz AK, Daumer K, Lisanti MP, Frank PG. A Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer. The American Journal of Pathology. 177: 3180-91. PMID 21088217 DOI: 10.2353/ajpath.2010.100568  1
2010 Pavlides S, Tsirigos A, Migneco G, Whitaker-Menezes D, Chiavarina B, Flomenberg N, Frank PG, Casimiro MC, Wang C, Pestell RG, Martinez-Outschoorn UE, Howell A, Sotgia F, Lisanti MP. The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism. Cell Cycle (Georgetown, Tex.). 9: 3485-505. PMID 20861672 DOI: 10.4161/cc.9.17.12721  1
2010 Bonuccelli G, Tsirigos A, Whitaker-Menezes D, Pavlides S, Pestell RG, Chiavarina B, Frank PG, Flomenberg N, Howell A, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle (Georgetown, Tex.). 9: 3506-14. PMID 20818174 DOI: 10.4161/cc.9.17.12731  1
2010 Zhu H, Suk HY, Yu RY, Brancho D, Olabisi O, Yang TT, Yang X, Zhang J, Moussaif M, Durand JL, Jelicks LA, Kim JY, Scherer PE, Frank PG, Lisanti MP, et al. Evolutionarily conserved role of calcineurin in phosphodegron-dependent degradation of phosphodiesterase 4D. Molecular and Cellular Biology. 30: 4379-90. PMID 20647544 DOI: 10.1128/MCB.01193-09  1
2010 Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, Wang C, Fortina P, Addya S, Pestell RG, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation. Cell Cycle (Georgetown, Tex.). 9: 2201-19. PMID 20519932 DOI: 10.4161/cc.9.11.11848  1
2010 Bonuccelli G, Whitaker-Menezes D, Castello-Cros R, Pavlides S, Pestell RG, Fatatis A, Witkiewicz AK, Vander Heiden MG, Migneco G, Chiavarina B, Frank PG, Capozza F, Flomenberg N, Martinez-Outschoorn UE, Sotgia F, ... Lisanti MP, et al. The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts. Cell Cycle (Georgetown, Tex.). 9: 1960-71. PMID 20495363 DOI: 10.4161/cc.9.10.11601  1
2010 Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, Wang C, Pestell RG, Martinez-Outschoorn UE, Howell A, Sotgia F, Lisanti MP. Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling". Aging. 2: 185-99. PMID 20442453 DOI: v2/n4/full/100134.html  1
2010 Xie L, Frank PG, Lisanti MP, Sowa G. Endothelial cells isolated from caveolin-2 knockout mice display higher proliferation rate and cell cycle progression relative to their wild-type counterparts. American Journal of Physiology. Cell Physiology. 298: C693-701. PMID 20007452 DOI: 10.1152/ajpcell.00401.2009  1
2010 Gazzerro E, Sotgia F, Bruno C, Lisanti MP, Minetti C. Caveolinopathies: From the biology of caveolin-3 to human diseases European Journal of Human Genetics. 18: 137-145. PMID 19584897 DOI: 10.1038/ejhg.2009.103  1
2009 Jasmin JF, Yang M, Iacovitti L, Lisanti MP. Genetic ablation of caveolin-1 increases neural stem cell proliferation in the subventricular zone (SVZ) of the adult mouse brain Cell Cycle. 8: 3978-3983. PMID 19923909  1
2009 Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, Casimiro MC, Wang C, Fortina P, Addya S, Pestell RG, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle (Georgetown, Tex.). 8: 3984-4001. PMID 19923890  1
2009 Wu KN, Emmons RV, Lisanti MP, Farber JL, Witkiewicz AK. Foxp3-expressing T regulatory cells and mast cells in acute graft-versus-host disease of the skin. Cell Cycle (Georgetown, Tex.). 8: 3601-5. PMID 19838066  1
2009 Di Vizio D, Morello M, Sotgia F, Pestell RG, Freeman MR, Lisanti MP. An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation. Cell Cycle (Georgetown, Tex.). 8: 2420-4. PMID 19556867  1
2009 Witkiewicz AK, Casimiro MC, Dasgupta A, Mercier I, Wang C, Bonuccelli G, Jasmin JF, Frank PG, Pestell RG, Kleer CG, Sotgia F, Lisanti MP. Towards a new "stromal-based" classification system for human breast cancer prognosis and therapy. Cell Cycle (Georgetown, Tex.). 8: 1654-8. PMID 19448435  1
2009 Bonuccelli G, Casimiro MC, Sotgia F, Wang C, Liu M, Katiyar S, Zhou J, Dew E, Capozza F, Daumer KM, Minetti C, Milliman JN, Alpy F, Rio MC, Tomasetto C, ... ... Lisanti MP, et al. Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature. The American Journal of Pathology. 174: 1650-62. PMID 19395651 DOI: 10.2353/ajpath.2009.080648  1
2009 Mercier I, Casimiro MC, Zhou J, Wang C, Plymire C, Bryant KG, Daumer KM, Sotgia F, Bonuccelli G, Witkiewicz AK, Lin J, Tran TH, Milliman J, Frank PG, Jasmin JF, ... ... Lisanti MP, et al. Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions. The American Journal of Pathology. 174: 1172-90. PMID 19342371 DOI: 10.2353/ajpath.2009.080882  1
2009 Mercier I, Jasmin JF, Pavlides S, Minetti C, Flomenberg N, Pestell RG, Frank PG, Sotgia F, Lisanti MP. Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders. Laboratory Investigation; a Journal of Technical Methods and Pathology. 89: 614-23. PMID 19333235 DOI: 10.1038/labinvest.2009.23  1
2009 Sotgia F, Del Galdo F, Casimiro MC, Bonuccelli G, Mercier I, Whitaker-Menezes D, Daumer KM, Zhou J, Wang C, Katiyar S, Xu H, Bosco E, Quong AA, Aronow B, Witkiewicz AK, ... ... Lisanti MP, et al. Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts. The American Journal of Pathology. 174: 746-61. PMID 19234134 DOI: 10.2353/ajpath.2009.080658  1
2009 Marmon S, Hinchey J, Oh P, Cammer M, de Almeida CJ, Gunther L, Raine CS, Lisanti MP. Caveolin-1 expression determines the route of neutrophil extravasation through skin microvasculature. The American Journal of Pathology. 174: 684-92. PMID 19164603 DOI: 10.2353/ajpath.2009.080091  1
2009 Sotgia F, Casimiro MC, Bonuccelli G, Liu M, Whitaker-Menezes D, Er O, Daumer KM, Mercier I, Witkiewicz AK, Minetti C, Capozza F, Gormley M, Quong AA, Rui H, Frank PG, ... ... Lisanti MP, et al. Loss of caveolin-3 induces a lactogenic microenvironment that is protective against mammary tumor formation. The American Journal of Pathology. 174: 613-29. PMID 19164602 DOI: 10.2353/ajpath.2009.080653  1
2009 Marmon S, Cammer M, Raine CS, Lisanti MP. Transcellular migration of neutrophils is a quantitatively significant pathway across dermal microvascular endothelial cells. Experimental Dermatology. 18: 88-90. PMID 19040450 DOI: 10.1111/j.1600-0625.2008.00796.x  1
2009 Marmon S, Hinchey J, Raine CS, Lisanti MP. Chemokine transport and leukocyte extravasation through dermal microvasculature in the absence of caveolae. Journal of Dermatological Science. 53: 225-8. PMID 19019633 DOI: 10.1016/j.jdermsci.2008.09.006  1
2009 Frank PG, Pavlides S, Lisanti MP. Caveolae and transcytosis in endothelial cells: role in atherosclerosis. Cell and Tissue Research. 335: 41-7. PMID 18688651 DOI: 10.1007/s00441-008-0659-8  1
2008 Okamoto T, Okamoto L, Lisanti MP, Akishita M. Switch to oral hypoglycemic agent therapy from insulin injection in patients with type 2 diabetes. Geriatrics & Gerontology International. 8: 218-26. PMID 19149832 DOI: 10.1111/j.1447-0594.2008.00477.x  1
2008 Frank PG, Lisanti MP. ICAM-1: role in inflammation and in the regulation of vascular permeability. American Journal of Physiology. Heart and Circulatory Physiology. 295: H926-H927. PMID 18689494 DOI: 10.1152/ajpheart.00779.2008  1
2008 Kim M, Wu X, Song I, Fu M, Chang SH, Lisanti MP, Pestell R. Selective cytotoxicity of synthesized procyanidin 3-O-galloylepicatechin- 4b, 8-3-O-galloylcatechin to human cancer cells Cell Cycle. 7: 1648-1657. PMID 18560275  1
2008 Frank PG, Pavlides S, Cheung MW, Daumer K, Lisanti MP. Role of caveolin-1 in the regulation of lipoprotein metabolism. American Journal of Physiology. Cell Physiology. 295: C242-8. PMID 18508910 DOI: 10.1152/ajpcell.00185.2008  1
2008 Gioiosa L, Raggi C, Ricceri L, Jasmin JF, Frank PG, Capozza F, Lisanti MP, Alleva E, Sargiacomo M, Laviola G. Altered emotionality, spatial memory and cholinergic function in caveolin-1 knock-out mice. Behavioural Brain Research. 188: 255-62. PMID 18083242 DOI: 10.1016/j.bbr.2007.11.002  1
2008 Lisanti MP. What's next at AJP? American Journal of Pathology. 173: 1. DOI: 10.2353/ajpath.2008.080390  1
2007 Di Vizio D, Sotgia F, Williams TM, Hassan GS, Capozza F, Frank PG, Pestell RG, Loda M, Freeman MR, Lisanti MP. Caveolin-1 is required for the upregulation of fatty acid synthase (FASN), a tumor promoter, during prostate cancer progression. Cancer Biology & Therapy. 6: 1263-8. PMID 17786030  1
2007 Frank PG, Hassan GS, Rodriguez-Feo JA, Lisanti MP. Caveolae and caveolin-1: novel potential targets for the treatment of cardiovascular disease. Current Pharmaceutical Design. 13: 1761-9. PMID 17584106 DOI: 10.2174/138161207780831202  1
2007 Hulit J, Suyama K, Chung S, Keren R, Agiostratidou G, Shan W, Dong X, Williams TM, Lisanti MP, Knudsen K, Hazan RB. N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation. Cancer Research. 67: 3106-16. PMID 17409417 DOI: 10.1158/0008-5472.CAN-06-3401  1
2007 Medina FA, Cohen AW, de Almeida CJ, Nagajyothi F, Braunstein VL, Teixeira MM, Tanowitz HB, Lisanti MP. Immune dysfunction in caveolin-1 null mice following infection with Trypanosoma cruzi (Tulahuen strain). Microbes and Infection / Institut Pasteur. 9: 325-33. PMID 17317261 DOI: 10.1016/j.micinf.2006.12.011  1
2007 Frank PG, Lisanti MP. Caveolin-1 and liver regeneration: role in proliferation and lipogenesis. Cell Cycle (Georgetown, Tex.). 6: 115-6. PMID 17314510  1
2007 Jasmin JF, Malhotra S, Singh Dhallu M, Mercier I, Rosenbaum DM, Lisanti MP. Caveolin-1 deficiency increases cerebral ischemic injury. Circulation Research. 100: 721-9. PMID 17293479 DOI: 10.1161/01.RES.0000260180.42709.29  1
2007 Katiyar S, Jiao X, Wagner E, Lisanti MP, Pestell RG. Somatic excision demonstrates that c-Jun induces cellular migration and invasion through induction of stem cell factor Molecular and Cellular Biology. 27: 1356-1369. PMID 17145782 DOI: 10.1128/MCB.01061-06  1
2006 Frank PG, Lisanti MP. Zebrafish as a novel model system to study the function of caveolae and caveolin-1 in organismal biology. The American Journal of Pathology. 169: 1910-2. PMID 17148656 DOI: 10.2353/ajpath.2006.060923  1
2006 Williams TM, Sotgia F, Lee H, Hassan G, Di Vizio D, Bonuccelli G, Capozza F, Mercier I, Rui H, Pestell RG, Lisanti MP. Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells. The American Journal of Pathology. 169: 1784-801. PMID 17071600 DOI: 10.2353/ajpath.2006.060590  0.88
2006 Medina FA, de Almeida CJ, Dew E, Li J, Bonuccelli G, Williams TM, Cohen AW, Pestell RG, Frank PG, Tanowitz HB, Lisanti MP. Caveolin-1-deficient mice show defects in innate immunity and inflammatory immune response during Salmonella enterica serovar Typhimurium infection. Infection and Immunity. 74: 6665-74. PMID 16982844 DOI: 10.1128/IAI.00949-06  1
2006 Hnasko R, Carter JM, Medina F, Frank PG, Lisanti MP. PV-1 labels trans-cellular openings in mouse endothelial cells and is negatively regulated by VEGF. Cell Cycle (Georgetown, Tex.). 5: 2021-8. PMID 16969078  1
2006 Hnasko R, Frank PG, Ben-Jonathan N, Lisanti MP. PV-1 is negatively regulated by VEGF in the lung of caveolin-1, but not caveolin-2, null mice. Cell Cycle (Georgetown, Tex.). 5: 2012-20. PMID 16969073  1
2006 Jasmin JF, Mercier I, Dupuis J, Tanowitz HB, Lisanti MP. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy Circulation. 114: 912-920. PMID 16940204 DOI: 10.1161/CIRCULATIONAHA.106.634709  1
2006 Medina FA, Williams TM, Sotgia F, Tanowitz HB, Lisanti MP. A novel role for caveolin-1 in B lymphocyte function and the development of thymus-independent immune responses. Cell Cycle (Georgetown, Tex.). 5: 1865-71. PMID 16929183  1
2006 Frank PG, Lisanti MP. Role of caveolin-1 in the regulation of the vascular shear stress response. The Journal of Clinical Investigation. 116: 1222-5. PMID 16670766 DOI: 10.1172/JCI28509  1
2006 Jasmin JF, Mercier I, Sotgia F, Lisanti MP. SOCS proteins and caveolin-1 as negative regulators of endocrine signaling Trends in Endocrinology and Metabolism. 17: 150-158. PMID 16616514 DOI: 10.1016/j.tem.2006.03.007  1
2006 Frank PG, Lisanti MP. Defining lipid raft structure and function with proximity imaging. American Journal of Physiology. Heart and Circulatory Physiology. 290: H2165-6. PMID 16428346 DOI: 10.1152/ajpheart.00041.2006  1
2006 Sotgia F, Schubert W, Pestell RG, Lisanti MP. Genetic ablation of caveolin-1 in mammary epithelial cells increases milk production and hyper-activates STAT5a signaling Cancer Biology and Therapy. 5: 292-297. PMID 16418573  1
2006 Hassan GS, Williams TM, Frank PG, Lisanti MP. Caveolin-1-deficient aortic smooth muscle cells show cell autonomous abnormalities in proliferation, migration, and endothelin-based signal transduction. American Journal of Physiology. Heart and Circulatory Physiology. 290: H2393-401. PMID 16415072 DOI: 10.1152/ajpheart.01161.2005  1
2006 Khan EM, Heidinger JM, Levy M, Lisanti MP, Ravid T, Goldkorn T. Epidermal growth factor receptor exposed to oxidative stress undergoes Src- and caveolin-1-dependent perinuclear trafficking. The Journal of Biological Chemistry. 281: 14486-93. PMID 16407214 DOI: 10.1074/jbc.M509332200  1
2006 Sotgia F, Williams TM, Schubert W, Medina F, Minetti C, Pestell RG, Lisanti MP. Caveolin-1 deficiency (-/-) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness. The American Journal of Pathology. 168: 292-309. PMID 16400031 DOI: 10.2353/ajpath.2006.050429  1
2006 Lee H, Xie L, Luo Y, Lee SY, Lawrence DS, Wang XB, Sotgia F, Lisanti MP, Zhang ZY. Identification of phosphocaveolin-1 as a novel protein tyrosine phosphatase 1B substrate. Biochemistry. 45: 234-40. PMID 16388599 DOI: 10.1021/bi051560j  1
2006 Alileche A, Squires RC, Muehlbauer SM, Lisanti MP, Brojatsch J. Mitochondrial impairment is a critical event in anthrax lethal toxin-induced cytolysis of murine macrophages. Cell Cycle (Georgetown, Tex.). 5: 100-6. PMID 16357526  1
2005 Li J, Hassan GS, Williams TM, Minetti C, Pestell RG, Tanowitz HB, Frank PG, Sotgia F, Lisanti MP. Loss of caveolin-1 causes the hyper-proliferation of intestinal crypt stem cells, with increased sensitivity to whole body gamma-radiation. Cell Cycle (Georgetown, Tex.). 4: 1817-25. PMID 16294037  1
2005 Sotgia F, Williams TM, Cohen AW, Minetti C, Pestell RG, Lisanti MP. Caveolin-1-deficient mice have an increased mammary stem cell population with upregulation of Wnt/beta-catenin signaling. Cell Cycle (Georgetown, Tex.). 4: 1808-16. PMID 16294019  1
2005 Fine SW, Lisanti MP, Argani P, Li M. Caveolin-3 is a sensitive and specific marker for rhabdomyosarcoma Applied Immunohistochemistry and Molecular Morphology. 13: 231-236. PMID 16082247 DOI: 10.1097/00129039-200509000-00003  1
2005 Iyengar P, Espina V, Williams TW, Lin Y, Berry D, Jelicks LA, Lee H, Temple K, Graves R, Pollard J, Chopra N, Russell RG, Sasisekharan R, Trock BJ, Lippman M, ... ... Lisanti MP, et al. Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. The Journal of Clinical Investigation. 115: 1163-76. PMID 15841211 DOI: 10.1172/JCI23424  1
2005 Williams TM, Hassan GS, Li J, Cohen AW, Medina F, Frank PG, Pestell RG, Di Vizio D, Loda M, Lisanti MP. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. The Journal of Biological Chemistry. 280: 25134-45. PMID 15802273 DOI: 10.1074/jbc.M501186200  1
2005 Cohen AW, Schubert W, Brasaemle DL, Scherer PE, Lisanti MP. Caveolin-1 expression is essential for proper nonshivering thermogenesis in brown adipose tissue. Diabetes. 54: 679-86. PMID 15734843 DOI: 10.2337/diabetes.54.3.679  1
2005 De Souza AP, Cohen AW, Park DS, Woodman SE, Tang B, Gutstein DE, Factor SM, Tanowitz HB, Lisanti MP, Jelicks LA. MR imaging of caveolin gene-specific alterations in right ventricular wall thickness. Magnetic Resonance Imaging. 23: 61-8. PMID 15733789 DOI: 10.1016/j.mri.2004.11.011  1
2005 Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. American Journal of Physiology. Cell Physiology. 288: C494-506. PMID 15692148 DOI: 10.1152/ajpcell.00458.2004  1
2005 Capozza F, Combs TP, Cohen AW, Cho YR, Park SY, Schubert W, Williams TM, Brasaemle DL, Jelicks LA, Scherer PE, Kim JK, Lisanti MP. Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle. American Journal of Physiology. Cell Physiology. 288: C1317-31. PMID 15689413 DOI: 10.1152/ajpcell.00489.2004  1
2005 Bonuccelli G, Sotgia F, Frank PG, Williams TM, de Almeida CJ, Tanowitz HB, Scherer PE, Hotchkiss KA, Terman BI, Rollman B, Alileche A, Brojatsch J, Lisanti MP. ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infection. American Journal of Physiology. Cell Physiology. 288: C1402-10. PMID 15689409 DOI: 10.1152/ajpcell.00582.2004  1
2005 Capozza F, Cohen AW, Cheung MW, Sotgia F, Schubert W, Battista M, Lee H, Frank PG, Lisanti MP. Muscle-specific interaction of caveolin isoforms: differential complex formation between caveolins in fibroblastic vs. muscle cells. American Journal of Physiology. Cell Physiology. 288: C677-91. PMID 15548572 DOI: 10.1152/ajpcell.00232.2004  1
2005 Jasmin JF, Frank PG, Lisanti MP. Chapter 11 Caveolin Proteins in Cardiopulmonary Disease and Lung Cancers Advances in Molecular and Cell Biology. 36: 211-233. DOI: 10.1016/S1569-2558(05)36011-5  1
2005 Hassan GS, Lisanti MP, Frank PG. Chapter 10 Caveolae and Caveolins in the Vascular System: Functional Roles in Endothelia, Macrophages, and Smooth Muscle Cells Advances in Molecular and Cell Biology. 36: 187-209. DOI: 10.1016/S1569-2558(05)36010-3  1
2004 Williams TM, Lisanti MP. The Caveolin genes: from cell biology to medicine. Annals of Medicine. 36: 584-95. PMID 15768830 DOI: 10.1080/07853890410018899  1
2004 Bouras T, Lisanti MP, Pestell RG. Caveolin-1 in breast cancer Cancer Biology and Therapy. 3: 931-941. PMID 15539932  1
2004 Wang XB, Lee H, Capozza F, Marmon S, Sotgia F, Brooks JW, Campos-Gonzalez R, Lisanti MP. Tyrosine phosphorylation of caveolin-2 at residue 27: differences in the spatial and temporal behavior of phospho-Cav-2 (pY19 and pY27). Biochemistry. 43: 13694-706. PMID 15504032 DOI: 10.1021/bi049295+  1
2004 Cohen AW, Hnasko R, Schubert W, Lisanti MP. Role of caveolae and caveolins in health and disease. Physiological Reviews. 84: 1341-79. PMID 15383654 DOI: 10.1152/physrev.00046.2003  1
2004 Frank PG, Lisanti MP. Caveolin-1 and caveolae in atherosclerosis: differential roles in fatty streak formation and neointimal hyperplasia. Current Opinion in Lipidology. 15: 523-9. PMID 15361787 DOI: 10.1097/00041433-200410000-00005  1
2004 Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG, Lisanti MP. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. The Journal of Biological Chemistry. 279: 51630-46. PMID 15355971 DOI: 10.1074/jbc.M409214200  0.88
2004 Berg AH, Lin Y, Lisanti MP, Scherer PE. Adipocyte differentiation induces dynamic changes in NF-kappaB expression and activity. American Journal of Physiology. Endocrinology and Metabolism. 287: E1178-88. PMID 15251865 DOI: 10.1152/ajpendo.00002.2004  1
2004 Hassan GS, Jasmin JF, Schubert W, Frank PG, Lisanti MP. Caveolin-1 deficiency stimulates neointima formation during vascular injury. Biochemistry. 43: 8312-21. PMID 15222744 DOI: 10.1021/bi049609t  1
2004 Cohen AW, Razani B, Schubert W, Williams TM, Wang XB, Iyengar P, Brasaemle DL, Scherer PE, Lisanti MP. Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes. 53: 1261-70. PMID 15111495 DOI: 10.2337/diabetes.53.5.1261  1
2004 Williams TM, Lee H, Cheung MW, Cohen AW, Razani B, Iyengar P, Scherer PE, Pestell RG, Lisanti MP. Combined loss of INK4a and caveolin-1 synergistically enhances cell proliferation and oncogene-induced tumorigenesis: role of INK4a/CAV-1 in mammary epithelial cell hyperplasia. The Journal of Biological Chemistry. 279: 24745-56. PMID 15044451 DOI: 10.1074/jbc.M402064200  1
2004 Williams TM, Lisanti MP. The caveolin proteins. Genome Biology. 5: 214. PMID 15003112 DOI: 10.1186/gb-2004-5-3-214  1
2004 Woodman SE, Sotgia F, Galbiati F, Minetti C, Lisanti MP. Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases. Neurology. 62: 538-43. PMID 14981167  1
2004 Woodman SE, Cheung MW, Tarr M, North AC, Schubert W, Lagaud G, Marks CB, Russell RG, Hassan GS, Factor SM, Christ GJ, Lisanti MP. Urogenital alterations in aged male caveolin-1 knockout mice. The Journal of Urology. 171: 950-7. PMID 14713860 DOI: 10.1097/01.ju.0000105102.72295.b8  1
2004 Frank PG, Lee H, Park DS, Tandon NN, Scherer PE, Lisanti MP. Genetic ablation of caveolin-1 confers protection against atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 24: 98-105. PMID 14563650 DOI: 10.1161/01.ATV.0000101182.89118.E5  1
2003 Hnasko R, Lisanti MP. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease Mol Interv. 3: 445-464. PMID 14993453  1
2003 Park DS, Cohen AW, Frank PG, Razani B, Lee H, Williams TM, Chandra M, Shirani J, De Souza AP, Tang B, Jelicks LA, Factor SM, Weiss LM, Tanowitz HB, Lisanti MP. Caveolin-1 null (-/-) mice show dramatic reductions in life span. Biochemistry. 42: 15124-31. PMID 14690422 DOI: 10.1021/bi0356348  1
2003 Sotgia F, Bonuccelli G, Minetti C, Woodman SE, Capozza F, Kemp RG, Scherer PE, Lisanti MP. Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases. The American Journal of Pathology. 163: 2619-34. PMID 14633633 DOI: 10.1016/S0002-9440(10)63616-4  1
2003 Cohen AW, Combs TP, Scherer PE, Lisanti MP. Role of caveolin and caveolae in insulin signaling and diabetes. American Journal of Physiology. Endocrinology and Metabolism. 285: E1151-60. PMID 14607781 DOI: 10.1152/ajpendo.00324.2003  1
2003 Bonuccelli G, Sotgia F, Schubert W, Park DS, Frank PG, Woodman SE, Insabato L, Cammer M, Minetti C, Lisanti MP. Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins. The American Journal of Pathology. 163: 1663-75. PMID 14507673 DOI: 10.1016/S0002-9440(10)63523-7  1
2003 Fong A, Garcia E, Gwynn L, Lisanti MP, Fazzari MJ, Li M. Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation American Journal of Clinical Pathology. 120: 93-100. PMID 12866378 DOI: 10.1309/292N-HAYN-WAVR-EJ37  1
2003 Sotgia F, Woodman SE, Bonuccelli G, Capozza F, Minetti C, Scherer PE, Lisanti MP. Phenotypic behavior of caveolin-3 R26Q, a mutant associated with hyperCKemia, distal myopathy, and rippling muscle disease. American Journal of Physiology. Cell Physiology. 285: C1150-60. PMID 12839838 DOI: 10.1152/ajpcell.00166.2003  1
2003 Woodman SE, Ashton AW, Schubert W, Lee H, Williams TM, Medina FA, Wyckoff JB, Combs TP, Lisanti MP. Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli. The American Journal of Pathology. 162: 2059-68. PMID 12759260 DOI: 10.1016/S0002-9440(10)64337-4  1
2003 Capozza F, Williams TM, Schubert W, McClain S, Bouzahzah B, Sotgia F, Lisanti MP. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation. The American Journal of Pathology. 162: 2029-39. PMID 12759258 DOI: 10.1016/S0002-9440(10)64335-0  0.88
2003 Frank PG, Woodman SE, Park DS, Lisanti MP. Caveolin, caveolae, and endothelial cell function. Arteriosclerosis, Thrombosis, and Vascular Biology. 23: 1161-8. PMID 12689915 DOI: 10.1161/01.ATV.0000070546.16946.3A  1
2003 Cohen AW, Razani B, Wang XB, Combs TP, Williams TM, Scherer PE, Lisanti MP. Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. American Journal of Physiology. Cell Physiology. 285: C222-35. PMID 12660144 DOI: 10.1152/ajpcell.00006.2003  1
2003 Williams TM, Cheung MW, Park DS, Razani B, Cohen AW, Muller WJ, Di Vizio D, Chopra NG, Pestell RG, Lisanti MP. Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice. Molecular Biology of the Cell. 14: 1027-42. PMID 12631721 DOI: 10.1091/mbc.E02-08-0503  1
2003 Cohen AW, Park DS, Woodman SE, Williams TM, Chandra M, Shirani J, Pereira de Souza A, Kitsis RN, Russell RG, Weiss LM, Tang B, Jelicks LA, Factor SM, Shtutin V, Tanowitz HB, ... Lisanti MP, et al. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. American Journal of Physiology. Cell Physiology. 284: C457-74. PMID 12388077 DOI: 10.1152/ajpcell.00380.2002  1
2002 Park DS, Lee H, Frank PG, Razani B, Nguyen AV, Parlow AF, Russell RG, Hulit J, Pestell RG, Lisanti MP. Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2/STAT5a signaling cascade. Molecular Biology of the Cell. 13: 3416-30. PMID 12388746 DOI: 10.1091/mbc.02-05-0071  1
2002 Lee H, Park DS, Razani B, Russell RG, Pestell RG, Lisanti MP. Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia. The American Journal of Pathology. 161: 1357-69. PMID 12368209 DOI: 10.1016/S0002-9440(10)64412-4  1
2002 Razani B, Woodman SE, Lisanti MP. Caveolae: from cell biology to animal physiology. Pharmacological Reviews. 54: 431-67. PMID 12223531 DOI: 10.1124/pr.54.3.431  1
2002 Schubert W, Frank PG, Woodman SE, Hyogo H, Cohen DE, Chow CW, Lisanti MP. Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice. The Journal of Biological Chemistry. 277: 40091-8. PMID 12167625 DOI: 10.1074/jbc.M205948200  1
2002 Woodman SE, Park DS, Cohen AW, Cheung MW, Chandra M, Shirani J, Tang B, Jelicks LA, Kitsis RN, Christ GJ, Factor SM, Tanowitz HB, Lisanti MP. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. The Journal of Biological Chemistry. 277: 38988-97. PMID 12138167 DOI: 10.1074/jbc.M205511200  1
2002 Volonte D, Zhang K, Lisanti MP, Galbiati F. Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts: Stress-induced premature senescence upregulates the expression of endogenous caveolin-1 Molecular Biology of the Cell. 13: 2502-2517. PMID 12134086 DOI: 10.1091/mbc.01-11-0529  1
2002 Lee H, Park DS, Wang XB, Scherer PE, Schwartz PE, Lisanti MP. Src-induced phosphorylation of caveolin-2 on tyrosine 19. Phospho-caveolin-2 (Tyr(P)19) is localized near focal adhesions, remains associated with lipid rafts/caveolae, but no longer forms a high molecular mass hetero-oligomer with caveolin-1. The Journal of Biological Chemistry. 277: 34556-67. PMID 12091389 DOI: 10.1074/jbc.M204367200  0.76
2002 Razani B, Park DS, Miyanaga Y, Ghatpande A, Cohen J, Wang XB, Scherer PE, Evans T, Lisanti MP. Molecular cloning and developmental expression of the caveolin gene family in the amphibian Xenopus laevis. Biochemistry. 41: 7914-24. PMID 12069580 DOI: 10.1021/bi020043n  1
2002 Park DS, Woodman SE, Schubert W, Cohen AW, Frank PG, Chandra M, Shirani J, Razani B, Tang B, Jelicks LA, Factor SM, Weiss LM, Tanowitz HB, Lisanti MP. Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. The American Journal of Pathology. 160: 2207-17. PMID 12057923 DOI: 10.1016/S0002-9440(10)61168-6  1
2002 Sotgia F, Razani B, Bonuccelli G, Schubert W, Battista M, Lee H, Capozza F, Schubert AL, Minetti C, Buckley JT, Lisanti MP. Intracellular retention of glycosylphosphatidyl inositol-linked proteins in caveolin-deficient cells. Molecular and Cellular Biology. 22: 3905-26. PMID 11997523 DOI: 10.1128/MCB.22.11.3905-3926.2002  1
2002 Schubert AL, Schubert W, Spray DC, Lisanti MP. Connexin family members target to lipid raft domains and interact with caveolin-1. Biochemistry. 41: 5754-64. PMID 11980479 DOI: 10.1021/bi0121656  1
2002 Woodman SE, Schlegel A, Cohen AW, Lisanti MP. Mutational analysis identifies a short atypical membrane attachment sequence (KYWFYR) within caveolin-1. Biochemistry. 41: 3790-5. PMID 11888297 DOI: 10.1021/bi0120751  1
2002 Razani B, Wang XB, Engelman JA, Battista M, Lagaud G, Zhang XL, Kneitz B, Hou H, Christ GJ, Edelmann W, Lisanti MP. Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Molecular and Cellular Biology. 22: 2329-44. PMID 11884617 DOI: 10.1128/MCB.22.7.2329-2344.2002  1
2002 Liu J, Wang XB, Park DS, Lisanti MP. Caveolin-1 expression enhances endothelial capillary tubule formation Journal of Biological Chemistry. 277: 10661-10668. PMID 11748236 DOI: 10.1074/jbc.M110354200  1
2002 Razani B, Combs TP, Wang XB, Frank PG, Park DS, Russell RG, Li M, Tang B, Jelicks LA, Scherer PE, Lisanti MP. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. The Journal of Biological Chemistry. 277: 8635-47. PMID 11739396 DOI: 10.1074/jbc.M110970200  1
2001 Lisanti MP, Sargiacomo M. Biotinylation and analysis of membrane-bound and soluble proteins Current Protocols in Immunology / Edited by John E. Coligan ... [Et Al.]. PMID 18432856  1
2001 Okamoto T, Schwab RB, Scherer PE, Lisanti MP. Analysis of the association of proteins with membranes Current Protocols in Cell Biology / Editorial Board, Juan S. Bonifacino ... [Et Al.]. PMID 18228372  1
2001 Razani B, Lisanti MP. Caveolin-deficient mice: insights into caveolar function human disease. The Journal of Clinical Investigation. 108: 1553-61. PMID 11733547 DOI: 10.1172/JCI14611  1
2001 Sotgia F, Lee H, Bedford MT, Petrucci T, Sudol M, Lisanti MP. Tyrosine phosphorylation of beta-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins. Biochemistry. 40: 14585-92. PMID 11724572 DOI: 10.1021/bi011247r  1
2001 Razani B, Lisanti MP. Caveolins and caveolae: molecular and functional relationships. Experimental Cell Research. 271: 36-44. PMID 11697880 DOI: 10.1006/excr.2001.5372  1
2001 Schubert W, Frank PG, Razani B, Park DS, Chow CW, Lisanti MP. Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo. The Journal of Biological Chemistry. 276: 48619-22. PMID 11689550 DOI: 10.1074/jbc.C100613200  1
2001 Park DS, Lee H, Riedel C, Hulit J, Scherer PE, Pestell RG, Lisanti MP. Prolactin negatively regulates caveolin-1 gene expression in the mammary gland during lactation, via a Ras-dependent mechanism. The Journal of Biological Chemistry. 276: 48389-97. PMID 11602600 DOI: 10.1074/jbc.M108210200  1
2001 Galbiati F, Razani B, Lisanti MP. Caveolae and caveolin-3 in muscular dystrophy. Trends in Molecular Medicine. 7: 435-41. PMID 11597517 DOI: 10.1016/S1471-4914(01)02105-0  1
2001 Schlegel A, Wang C, Pestell RG, Lisanti MP. Ligand-independent activation of oestrogen receptor alpha by caveolin-1. The Biochemical Journal. 359: 203-10. PMID 11563984 DOI: 10.1042/0264-6021:3590203  1
2001 Razani B, Lisanti MP. Two distinct caveolin-1 domains mediate the functional interaction of caveolin-1 with protein kinase A. American Journal of Physiology. Cell Physiology. 281: C1241-50. PMID 11546661  1
2001 Frank PG, Pedraza A, Cohen DE, Lisanti MP. Adenovirus-mediated expression of caveolin-1 in mouse liver increases plasma high-density lipoprotein levels Biochemistry. 40: 10892-10900. PMID 11535066 DOI: 10.1021/bi0106437  1
2001 Galbiati F, Razani B, Lisanti MP. Emerging themes in lipid rafts and caveolae. Cell. 106: 403-11. PMID 11525727 DOI: 10.1016/S0092-8674(01)00472-X  1
2001 Razani B, Schlegel A, Liu J, Lisanti MP. Caveolin-1, a putative tumour suppressor gene. Biochemical Society Transactions. 29: 494-9. PMID 11498016 DOI: 10.1042/BST0290494  1
2001 Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H, Kneitz B, Lagaud G, Christ GJ, ... ... Lisanti MP, et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. The Journal of Biological Chemistry. 276: 38121-38. PMID 11457855 DOI: 10.1074/jbc.M105408200  1
2001 Lee H, Woodman SE, Engelman JA, Volonté D, Galbiati F, Kaufman HL, Lublin DM, Lisanti MP. Palmitoylation of caveolin-1 at a single site (Cys-156) controls its coupling to the c-Src tyrosine kinase: targeting of dually acylated molecules (GPI-linked, transmembrane, or cytoplasmic) to caveolae effectively uncouples c-Src and caveolin-1 (TYR-14). The Journal of Biological Chemistry. 276: 35150-8. PMID 11451957 DOI: 10.1074/jbc.M104530200  1
2001 Fine SW, Lisanti MP, Galbiati F, Li M. Elevated expression of caveolin-1 in adenocarcinoma of the colon American Journal of Clinical Pathology. 115: 719-724. PMID 11345836 DOI: 10.1309/YL54-CCU7-4V0P-FDUT  1
2001 Schlegel A, Lisanti MP. The caveolin triad: caveolae biogenesis, cholesterol trafficking, and signal transduction. Cytokine & Growth Factor Reviews. 12: 41-51. PMID 11312118 DOI: 10.1016/S1359-6101(00)00022-8  1
2001 Frank PG, Galbiati F, Volonte D, Razani B, Cohen DE, Marcel YL, Lisanti MP. Influence of caveolin-1 on cellular cholesterol efflux mediated by high-density lipoproteins. American Journal of Physiology. Cell Physiology. 280: C1204-14. PMID 11287334  1
2001 Galbiati F, Engelman JA, Volonte D, Zhang XL, Minetti C, Li M, Hou H, Kneitz B, Edelmann W, Lisanti MP. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. The Journal of Biological Chemistry. 276: 21425-33. PMID 11259414 DOI: 10.1074/jbc.M100828200  1
2001 Park DS, Razani B, Lasorella A, Schreiber-Agus N, Pestell RG, Iavarone A, Lisanti MP. Evidence that Myc isoforms transcriptionally repress caveolin-1 gene expression via an INR-dependent mechanism. Biochemistry. 40: 3354-62. PMID 11258956 DOI: 10.1021/bi002787b  1
2001 Liu J, Lee P, Galbiati F, Kitsis RN, Lisanti MP. Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulation. American Journal of Physiology. Cell Physiology. 280: C823-35. PMID 11245599  1
2001 Schlegel A, Lisanti MP. Caveolae and their coat proteins, the caveolins: from electron microscopic novelty to biological launching pad. Journal of Cellular Physiology. 186: 329-37. PMID 11169971 DOI: 10.1002/1097-4652(2001)9999:9999<000::AID-JCP1045>3.0.CO;2-0  1
2001 Razani B, Zhang XL, Bitzer M, von Gersdorff G, Böttinger EP, Lisanti MP. Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor. The Journal of Biological Chemistry. 276: 6727-38. PMID 11102446 DOI: 10.1074/jbc.M008340200  1
2001 Volonté D, Galbiati F, Pestell RG, Lisanti MP. Cellular stress induces the tyrosine phosphorylation of caveolin-1 (Tyr14) via activation of p38 mitogen-activated protein kinase and c-Src kinase. Evidence for caveolae, the actin cytoskeleton, and focal adhesions as mechanical sensors of osmotic stress Journal of Biological Chemistry. 276: 8094-8103. PMID 11094059 DOI: 10.1074/jbc.M009245200  1
2001 Schlegel A, Arvan P, Lisanti MP. Caveolin-1 binding to endoplasmic reticulum membranes and entry into the regulated secretory pathway are regulated by serine phosphorylation. Protein sorting at the level of the endoplasmic reticulum. The Journal of Biological Chemistry. 276: 4398-408. PMID 11078729 DOI: 10.1074/jbc.M005448200  1
2000 Schlegel A, Pestell RG, Lisanti MP. Caveolins in cholesterol trafficking and signal transduction: implications for human disease. Frontiers in Bioscience : a Journal and Virtual Library. 5: D929-37. PMID 11102315  1
2000 Razani B, Altschuler Y, Zhu L, Pestell RG, Mostov KE, Lisanti MP. Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation. Biochemistry. 39: 13916-24. PMID 11076533 DOI: 10.1021/bi001489b  1
2000 Lee H, Volonte D, Galbiati F, Iyengar P, Lublin DM, Bregman DB, Wilson MT, Campos-Gonzalez R, Bouzahzah B, Pestell RG, Scherer PE, Lisanti MP. Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Molecular Endocrinology (Baltimore, Md.). 14: 1750-75. PMID 11075810 DOI: 10.1210/mend.14.11.0553  0.72
2000 Engelman JA, Berg AH, Lewis RY, Lisanti MP, Scherer PE. Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes. Molecular Endocrinology (Baltimore, Md.). 14: 1557-69. PMID 11043572 DOI: 10.1210/mend.14.10.0542  1
2000 Rybin VO, Xu X, Lisanti MP, Steinberg SF. Differential targeting of β-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae: A mechanism to functionally regulate the cAMP signaling pathway Journal of Biological Chemistry. 275: 41447-41457. PMID 11006286 DOI: 10.1074/jbc.M006951200  1
2000 Galbiati F, Volonté D, Minetti C, Bregman DB, Lisanti MP. Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutants and rescues wild-type caveolin-3 Journal of Biological Chemistry. 275: 37702-37711. PMID 10973975 DOI: 10.1074/jbc.M006657200  1
2000 Razani B, Schlegel A, Lisanti MP. Caveolin proteins in signaling, oncogenic transformation and muscular dystrophy. Journal of Cell Science. 113: 2103-9. PMID 10825283  1
2000 Lin Y, Lee H, Berg AH, Lisanti MP, Shapiro L, Scherer PE. The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. The Journal of Biological Chemistry. 275: 24255-63. PMID 10823826 DOI: 10.1074/jbc.M002137200  1
2000 Schlegel A, Lisanti MP. A molecular dissection of caveolin-1 membrane attachment and oligomerization. Two separate regions of the caveolin-1 C-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo. The Journal of Biological Chemistry. 275: 21605-17. PMID 10801850 DOI: 10.1074/jbc.M002558200  1
2000 Zhang W, Razani B, Altschuler Y, Bouzahzah B, Mostov KE, Pestell RG, Lisanti MP. Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3). Transformation suppressor effects of adenovirus-mediated gene delivery of caveolin-1. The Journal of Biological Chemistry. 275: 20717-25. PMID 10748172 DOI: 10.1074/jbc.M909895199  1
2000 Hulit J, Bash T, Fu M, Galbiati F, Albanese C, Sage DR, Schlegel A, Zhurinsky J, Shtutman M, Ben-Ze'ev A, Lisanti MP, Pestell RG. The cyclin D1 gene is transcriptionally repressed by caveolin-1. The Journal of Biological Chemistry. 275: 21203-9. PMID 10747899 DOI: 10.1074/jbc.M000321200  1
1999 Engelman JA, Berg AH, Lewis RY, Lin A, Lisanti MP, Scherer PE. Constitutively active mitogen-activated protein kinase kinase 6 (MKK6) or salicylate induces spontaneous 3T3-L1 adipogenesis. The Journal of Biological Chemistry. 274: 35630-8. PMID 10585441 DOI: 10.1074/jbc.274.50.35630  1
1999 Schlegel A, Wang C, Katzenellenbogen BS, Pestell RG, Lisanti MP. Caveolin-1 potentiates estrogen receptor alpha (ERalpha) signaling. caveolin-1 drives ligand-independent nuclear translocation and activation of ERalpha. The Journal of Biological Chemistry. 274: 33551-6. PMID 10559241 DOI: 10.1074/jbc.274.47.33551  1
1999 Engelman JA, Zhang XL, Razani B, Pestell RG, Lisanti MP. p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression. Activation of Ras-MAP kinase and protein kinase a signaling cascades transcriptionally down-regulates caveolin-1 promoter activity. The Journal of Biological Chemistry. 274: 32333-41. PMID 10542274 DOI: 10.1074/jbc.274.45.32333  1
1999 Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T, Lisanti MP. Caveolins, liquid-ordered domains, and signal transduction. Molecular and Cellular Biology. 19: 7289-304. PMID 10523618  1
1999 Galbiati F, Volonte D, Engelman JA, Scherer PE, Lisanti MP. Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation. The Journal of Biological Chemistry. 274: 30315-21. PMID 10514527 DOI: 10.1074/jbc.274.42.30315  1
1999 Razani B, Rubin CS, Lisanti MP. Regulation of cAMP-mediated signal transduction via interaction of caveolins with the catalytic subunit of protein kinase A. The Journal of Biological Chemistry. 274: 26353-60. PMID 10473592 DOI: 10.1074/jbc.274.37.26353  1
1999 Parolini I, Sargiacomo M, Galbiati F, Rizzo G, Grignani F, Engelman JA, Okamoto T, Ikezu T, Scherer PE, Mora R, Rodriguez-Boulan E, Peschle C, Lisanti MP. Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the golgi complex. The Journal of Biological Chemistry. 274: 25718-25. PMID 10464309 DOI: 10.1074/jbc.274.36.25718  1
1999 Galbiati F, Volonte D, Minetti C, Chu JB, Lisanti MP. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex. The Journal of Biological Chemistry. 274: 25632-41. PMID 10464299 DOI: 10.1074/jbc.274.36.25632  1
1999 Schlegel A, Schwab RB, Scherer PE, Lisanti MP. A role for the caveolin scaffolding domain in mediating the membrane attachment of caveolin-1. The caveolin scaffolding domain is both necessary and sufficient for membrane binding in vitro. The Journal of Biological Chemistry. 274: 22660-7. PMID 10428847 DOI: 10.1074/jbc.274.32.22660  1
1999 Lisanti MP, Sargiacomo M, Scherer PE. Purification of caveolae-derived membrane microdomains containing lipid-anchored signaling molecules, such as GPI-anchored proteins, H-Ras, Src-family tyrosine kinases, eNOS, and G-protein alpha-, beta-, and gamma-subunits Methods in Molecular Biology (Clifton, N.J.). 116: 51-60. PMID 10399145  1
1999 Sotgia F, Minetti C, Lisanti MP. Localization of the human caveolin-3 gene to the D3S18/D3S4163/D3S4539 locus (3p25), in close proximity to the human oxytocin receptor geneIdentification of the caveolin-3 gene as a candidate for deletion in 3p-syndrome Febs Letters. 452: 177-180. PMID 10386585 DOI: 10.1016/S0014-5793(99)00658-4  1
1999 Das K, Lewis RY, Scherer PE, Lisanti MP. The membrane-spanning domains of caveolins-1 and -2 mediate the formation of caveolin hetero-oligomers. Implications for tile assembly of caveolae membranes in vivo Journal of Biological Chemistry. 274: 18721-18728. PMID 10373486 DOI: 10.1074/jbc.274.26.18721  1
1999 Liu J, Razani B, Tang S, Terman BI, Ware JA, Lisanti MP. Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1. The Journal of Biological Chemistry. 274: 15781-5. PMID 10336480 DOI: 10.1074/jbc.274.22.15781  1
1999 Engelman JA, Zhang XL, Lisanti MP. Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). Methylation of a CpG island in the 5' promoter region of the caveolin-1 gene in human breast cancer cell lines. Febs Letters. 448: 221-30. PMID 10218480 DOI: 10.1016/S0014-5793(99)00365-8  1
1999 Volontè D, Galbiati F, Lisanti MP. Visualization of caveolin-1, a caveolar marker protein, in living cells using green fluorescent protein (GFP) chimeras. The subcellular distribution of caveolin-1 is modulated by cell-cell contact Febs Letters. 445: 431-439. PMID 10094502 DOI: 10.1016/S0014-5793(99)00164-7  1
1999 Carman CV, Lisanti MP, Benovic JL. Regulation of G protein-coupled receptor kinases by caveolin Journal of Biological Chemistry. 274: 8858-8864. PMID 10085129 DOI: 10.1074/jbc.274.13.8858  1
1999 Galbiati F, Volonté D, Meani D, Milligan G, Lublin DM, Lisanti MP, Parenti M. The dually acylated NH2-terminal domain of G(i1α) is sufficient to target a green fluorescent protein reporter to caveolin-enriched plasma membrane domains: Palmitoylation of caveolin-1 is required for the recognition of dually acylated G-protein α subunits in vivo Journal of Biological Chemistry. 274: 5843-5850. PMID 10026207 DOI: 10.1074/jbc.274.9.5843  1
1999 Bilderback TR, Gazula VR, Lisanti MP, Dobrowsky RT. Caveolin interacts with Trk A and p75(NTR) and regulates neurotrophin signaling pathways Journal of Biological Chemistry. 274: 257-263. PMID 9867838 DOI: 10.1074/jbc.274.1.257  1
1998 Yang CPH, Galbiati F, Volonté D, Horwitz SB, Lisanti MP. Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells Febs Letters. 439: 368-372. PMID 9845355 DOI: 10.1016/S0014-5793(98)01354-4  1
1998 Engelman JA, Zhang X, Galbiati F, Volonte D, Sotgia F, Pestell RG, Minetti C, Scherer PE, Okamoto T, Lisanti MP. Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy. American Journal of Human Genetics. 63: 1578-87. PMID 9837809 DOI: 10.1086/302172  1
1998 Engelman JA, Lisanti MP, Scherer PE. Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. The Journal of Biological Chemistry. 273: 32111-20. PMID 9822687 DOI: 10.1074/jbc.273.48.32111  1
1998 Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell RG, Lisanti MP. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. The Embo Journal. 17: 6633-48. PMID 9822607 DOI: 10.1093/emboj/17.22.6633  1
1998 Engelman JA, Zhang XL, Lisanti MP. Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers. Febs Letters. 436: 403-10. PMID 9801158 DOI: 10.1016/S0014-5793(98)01134-X  1
1998 Yamamoto M, Toya Y, Schwencke C, Lisanti MP, Myers MG, Ishikawa Y. Caveolin is an activator of insulin receptor signaling Journal of Biological Chemistry. 273: 26962-26968. PMID 9756945 DOI: 10.1074/jbc.273.41.26962  1
1998 Schlegel A, Volonte D, Engelman JA, Galbiati F, Mehta P, Zhang XL, Scherer PE, Lisanti MP. Crowded little caves: structure and function of caveolae. Cellular Signalling. 10: 457-63. PMID 9754713 DOI: 10.1016/S0898-6568(98)00007-2  1
1998 Li S, Galbiati F, Volonte D, Sargiacomo M, Engelman JA, Das K, Scherer PE, Lisanti MP. Mutational analysis of caveolin-induced vesicle formation. Expression of caveolin-1 recruits caveolin-2 to caveolae membranes. Febs Letters. 434: 127-34. PMID 9738464 DOI: 10.1016/S0014-5793(98)00945-4  1
1998 Galbiati F, Volonte D, Gil O, Zanazzi G, Salzer JL, Sargiacomo M, Scherer PE, Engelman JA, Schlegel A, Parenti M, Okamoto T, Lisanti MP. Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury. Proceedings of the National Academy of Sciences of the United States of America. 95: 10257-62. PMID 9707634 DOI: 10.1073/pnas.95.17.10257  1
1998 Engelman JA, Lee RJ, Karnezis A, Bearss DJ, Webster M, Siegel P, Muller WJ, Windle JJ, Pestell RG, Lisanti MP. Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer. The Journal of Biological Chemistry. 273: 20448-55. PMID 9685399 DOI: 10.1074/jbc.273.32.20448  1
1998 Engelman JA, Zhang XL, Galbiati F, Lisanti MP. Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1, -2, and -3). Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/7q31). Febs Letters. 429: 330-6. PMID 9662443 DOI: 10.1016/S0014-5793(98)00619-X  1
1998 Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, Kohtz DS, Lisanti MP. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. Febs Letters. 428: 205-11. PMID 9654135 DOI: 10.1016/S0014-5793(98)00470-0  1
1998 Crosbie RH, Yamada H, Venzke DP, Lisanti MP, Campbell KP. Caveolin-3 is not an integral component of the dystrophin glycoprotein complex. Febs Letters. 427: 279-82. PMID 9607328 DOI: 10.1016/S0014-5793(98)00442-6  1
1998 Ikezu T, Trapp BD, Song KS, Schlegel A, Lisanti MP, Okamoto T. Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor protein. The Journal of Biological Chemistry. 273: 10485-95. PMID 9553108 DOI: 10.1074/jbc.273.17.10485  1
1998 Toya Y, Schwencke C, Couet J, Lisanti MP, Ishikawa Y. Inhibition of adenylyl cyclase by caveolin peptides Endocrinology. 139: 2025-2031. PMID 9528990  1
1998 Okamoto T, Schlegel A, Scherer PE, Lisanti MP. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. The Journal of Biological Chemistry. 273: 5419-22. PMID 9488658 DOI: 10.1074/jbc.273.10.5419  1
1998 Breton S, Lisanti MP, Tyszkowski R, McLaughlin M, Brown D. Basolateral distribution of caveolin-1 in the kidney: Absence from H+- ATPase-coated endocytic vesicles in intercalated cells Journal of Histochemistry and Cytochemistry. 46: 205-214. PMID 9446827  1
1997 Couet J, Sargiacomo M, Lisanti MP. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities Journal of Biological Chemistry. 272: 30429-30438. PMID 9374534 DOI: 10.1074/jbc.272.48.30429  1
1997 Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, Couet J, Kohtz DS, van Donselaar E, Peters P, Lisanti MP. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. The Journal of Biological Chemistry. 272: 29337-46. PMID 9361015 DOI: 10.1074/jbc.272.46.29337  1
1997 Scherer PE, Lisanti MP. Association of phosphofructokinase-M with caveolin-3 in differentiated skeletal myotubes: Dynamic regulation by extracellular glucose and intracellular metabolites Journal of Biological Chemistry. 272: 20698-20705. PMID 9252390 DOI: 10.1074/jbc.272.33.20698  1
1997 Kübler E, Mösch HU, Rupp S, Lisanti MP. Gpa2p, a G-protein α-subunit, regulates growth and pseudohyphal development in Saccharomyces cerevisiae via a cAMP-dependent mechanism Journal of Biological Chemistry. 272: 20321-20323. PMID 9252333 DOI: 10.1074/jbc.272.33.20321  1
1997 Puertollano R, Li S, Lisanti MP, Alonso MA. Recombinant expression of the MAL proteolipid, a component of glycolipid-enriched membrane microdomains, induces the formation of vesicular structures in insect cells Journal of Biological Chemistry. 272: 18311-18315. PMID 9218471 DOI: 10.1074/jbc.272.29.18311  1
1997 Engelman JA, Wykoff CC, Yasuhara S, Song KS, Okamoto T, Lisanti MP. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. The Journal of Biological Chemistry. 272: 16374-81. PMID 9195944 DOI: 10.1074/jbc.272.26.16374  1
1997 Song KS, Sargiacomo M, Galbiati F, Parenti M, Lisanti MP. Targeting of a G alpha subunit (Gi1 alpha) and c-Src tyrosine kinase to caveolae membranes: clarifying the role of N-myristoylation Cellular and Molecular Biology (Noisy-Le-Grand, France). 43: 293-303. PMID 9193783  1
1997 Bickel PE, Scherer PE, Schnitzer JE, Oh P, Lisanti MP, Lodish HF. Flotillin and epidermal surface antigen define a new family of caveolae- associated integral membrane proteins Journal of Biological Chemistry. 272: 13793-13802. PMID 9153235 DOI: 10.1074/jbc.272.21.13793  1
1997 Song KS, Tang Z, Li S, Lisanti MP. Mutational analysis of the properties of caveolin-1. A novel role for the C-terminal domain in mediating homo-typic caveolin-caveolin interactions Journal of Biological Chemistry. 272: 4398-4403. PMID 9020162 DOI: 10.1074/jbc.272.7.4398  1
1997 Tang Z, Okamoto T, Boontrakulpoontawee P, Katada T, Otsuka AJ, Lisanti MP. Identification, sequence, and expression of an invertebrate caveolin gene family from the nematode Caenorhabditis elegans. Implications for the molecular evolution of mammalian caveolin genes. The Journal of Biological Chemistry. 272: 2437-45. PMID 8999956 DOI: 10.1074/jbc.272.4.2437  1
1997 Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP. Identification of peptide and protein ligands for the caveolin- scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins Journal of Biological Chemistry. 272: 6525-6533. DOI: 10.1074/jbc.272.10.6525  1
1997 Couet J, Shengwen L, Okamoto T, Scherer PE, Lisanti MP. Molecular and cellular biology of caveolae: Paradoxes and plasticities Trends in Cardiovascular Medicine. 7: 103-110. DOI: 10.1016/S1050-1738(97)00001-7  1
1996 Kübler E, Dohlman HG, Lisanti MP. Identification of Triton X-100 insoluble membrane domains in the yeast Saccharomyces cerevisiae: Lipid requirements for targeting of heterotrimeric G-protein subunits Journal of Biological Chemistry. 271: 32975-32980. PMID 8955141  1
1996 Li S, Couet J, Lisanti MP. Src tyrosine kinases, G(α) subunits, and H-Ras share a common membrane- anchored scaffolding protein, caveolin: Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases Journal of Biological Chemistry. 271: 29182-29190. PMID 8910575 DOI: 10.1074/jbc.271.46.29182  1
1996 Li S, Song KS, Koh SS, Kikuchi A, Lisanti MP. Baculovirus-based expression of mammalian caveolin in Sf21 insect cells: A model system for the biochemical and morphological study of caveolae biogenesis Journal of Biological Chemistry. 271: 28647-28654. PMID 8910498 DOI: 10.1074/jbc.271.45.28647  1
1996 Li S, Seitz R, Lisanti MP. Phosphorylation of caveolin by Src tyrosine kinases: The α-isoform of caveolin is selectively phosphorylated by v-Src in vivo Journal of Biological Chemistry. 271: 3863-3868. PMID 8632005  1
1996 Parolini I, Sargiacomo M, Lisanti MP, Peschle C. Signal transduction and glycophosphatidylinositol-linked proteins (LYN, LCK, CD4, CD45, G proteins, and CD55) selectively localize in triton-insoluble plasma membrane domains of human leukemic cell lines and normal granulocytes Blood. 87: 3783-3794. PMID 8611704  1
1996 Scherer PE, Okamoto T, Chun M, Nishimoto I, Lodish HF, Lisanti MP. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family Proceedings of the National Academy of Sciences of the United States of America. 93: 131-135. PMID 8552590 DOI: 10.1073/pnas.93.1.131  1
1996 Li S, Song KS, Lisanti MP. Expression and characterization of recombinant caveolin: Purification by polyhistidine tagging and cholesterol-dependent incorporation into defined lipid membranes Journal of Biological Chemistry. 271: 568-573. PMID 8550621  1
1995 Koleske AJ, Baltimore D, Lisanti MP. Reduction of caveolin and caveolae in oncogenically transformed cells. Proceedings of the National Academy of Sciences of the United States of America. 92: 1381-5. PMID 7877987 DOI: 10.1073/pnas.92.5.1381  1
1995 Kuliawat R, Lisanti MP, Arvan P. Polarized distribution and delivery of plasma membrane proteins in thyroid follicular epithelial cells Journal of Biological Chemistry. 270: 2478-2482. PMID 7852309 DOI: 10.1074/jbc.270.6.2478  1
1995 Lisanti MP, Tang Z, Scherer PE, Kübler E, Koleske AJ, Sargiacomo M. Caveolae, transmembrane signalling and cellular transformation. Molecular Membrane Biology. 12: 121-4. PMID 7767370 DOI: 10.3109/09687689509038506  1
1995 Lisanti MP, Tang Z, Scherer PE, Sargiacomo M. Caveolae purification and glycosylphosphatidylinositol-linked protein sorting in polarized epithelia Methods in Enzymology. 250: 655-668. PMID 7651184 DOI: 10.1016/0076-6879(95)50103-7  1
1995 Scherer PE, Tang Z, Chun M, Sargiacomo M, Lodish HF, Lisanti MP. Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution: Identification and epitope mapping of an isoform-specific monoclonal antibody probe Journal of Biological Chemistry. 270: 16395-16401. PMID 7608210  1
1995 Sargiacomo M, Scherer PE, Tang Z, Kübler E, Song KS, Sanders MC, Lisanti MP. Oligomeric structure of caveolin: Implications for caveolae membrane organization Proceedings of the National Academy of Sciences of the United States of America. 92: 9407-9411. PMID 7568142 DOI: 10.1073/pnas.92.20.9407  1
1995 Lisanti MP, Tang Z, Sargiacomo M. Caveolae: Portals for transmembrane signaling and cellular transport Membrane Protein Transport. 2: 111-122. DOI: 10.1016/S1874-592X(06)80006-5  1
1995 Lisanti MP, Tang Z, Scherer PE, Sargiacomo M. The apical sorting of glycosylphosphatidylinositol-linked proteins Membrane Protein Transport. 2: 97-110. DOI: 10.1016/S1874-592X(06)80005-3  1
1995 Lisanti MP, Scherer PE, Tang Z, Kübler E, Koleske AJ, Sargiacomo M. Caveolae and human disease: functional roles in transcytosis, potocytosis, signalling and cell polarity Seminars in Developmental Biology. 6: 47-58. DOI: 10.1016/S1044-5781(06)80084-8  1
1994 Sargiacomo M, Scherer PE, Tang Z, Casanova JE, Lisanti MP. In vitro phosphorylation of caveolin-rich membrane domains: Identification of an associated serine kinase activity as a casein kinase II-like enzyme Oncogene. 9: 2589-2595. PMID 8058322  1
1994 Chun M, Liyanage UK, Lisanti MP, Lodish HF. Signal transduction of a G protein-coupled receptor in caveolae: Colocalization of endothelin and its receptor with caveolin Proceedings of the National Academy of Sciences of the United States of America. 91: 11728-11732. PMID 7972131 DOI: 10.1073/pnas.91.24.11728  1
1994 Scherer PE, Lisanti MP, Baldini G, Sargiacomo M, Mastick CC, Lodish HF. Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles Journal of Cell Biology. 127: 1233-1243. PMID 7962086 DOI: 10.1083/jcb.127.5.1233  1
1994 Tang Z, Scherer PE, Lisanti MP. The primary sequence of murine caveolin reveals a conserved consensus site for phosphorylation by protein kinase C Gene. 147: 299-300. PMID 7926819 DOI: 10.1016/0378-1119(94)90087-6  1
1994 Lisanti MP, Scherer PE, Tang Z, Sargiacomo M. Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis Trends in Cell Biology. 4: 231-235. DOI: 10.1016/0962-8924(94)90114-7  1
1994 Lisanti MP. Reply Trends in Cell Biology. 4: 354. DOI: 10.1016/0962-8924(94)90078-7  1
1993 Hannan LA, Lisanti MP, Rodriguez-Boulan E, Edidin M. Correctly sorted molecules of a GPI-anchored protein are clustered and immobile when they arrive at the apical surface of MDCK cells Journal of Cell Biology. 120: 353-358. PMID 8380601  1
1993 Sargiacomo M, Sudol M, Tang Z, Lisanti MP. Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells Journal of Cell Biology. 122: 789-807. PMID 8349730  1
1993 Lisanti MP, Tang Z, Sargiacomo M. Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: Implications for the biogenesis of caveolae Journal of Cell Biology. 123: 595-604. PMID 8227128  1
1993 Zurzolo C, Lisanti MP, Caras IW, Nitsch L, Rodriguez-Boulan E. Glycosylphosphatidylinositol-anchored proteins are preferentially targeted to the basolateral surface in fischer rat thyroid epithelial cells Journal of Cell Biology. 121: 1031-1039. PMID 7684737  1
1992 Rosen CL, Lisanti MP, Salzer JL. Expression of unique sets of GPI-linked proteins by different primary neurons in vitro Journal of Cell Biology. 117: 617-627. PMID 1349305  1
1991 Lisanti MP, Field MC, Caras IW, Menon AK, Rodriguez-Boulan E. Mannosamine, a novel inhibitor of glycosylphosphatidylinositol incorporation into proteins. The Embo Journal. 10: 1969-77. PMID 1829673  1
1991 Lisanti MP, Rodríguez-Boulan E. Polarized sorting of GPI-linked proteins in epithelia and membrane microdomains Cell Biology International Reports. 15: 1023-1049. PMID 1782665 DOI: 10.1016/0309-1651(91)90054-M  1
1991 Lisanti MP, Caras IW, Rodriguez-Boulan E. Fusion proteins containing a minimal GPI-attachment signal are apically expressed in transfected MDCK cells Journal of Cell Science. 99: 637-640. PMID 1719008  1
1991 Powell SK, Lisanti MP, Rodriguez-Boulan EJ. Thy-1 expresses two signals for apical localization in epithelial cells. The American Journal of Physiology. 260: C715-20. PMID 1708202  1
1990 Lisanti MP, Caras IW, Gilbert T, Hanzel D, Rodriguez-Boulan E. Vectorial apical delivery and slow endocytosis of a glycolipid-anchored fusion protein in transfected MDCK cells Proceedings of the National Academy of Sciences of the United States of America. 87: 7419-7423. PMID 2145577  1
1990 Listani MP, Rodriguez-Boulan E, Saltiel AR. Emerging functional roles for the glycosyl-phosphatidylinositol membrane protein anchor Journal of Membrane Biology. 117: 1-10. PMID 2144878 DOI: 10.1007/BF01871561  0.64
1990 Lisanti MP, Rodriguez-Boulan E. Glycophospholipid membrane anchoring provides clues to the mechanism of protein sorting in polarized epithelial cells Trends in Biochemical Sciences. 15: 113-118. PMID 2139258 DOI: 10.1016/0968-0004(90)90195-H  1
1990 Lisanti MP, Le Bivic A, Saltiel AR, Rodriguez-Boulan E. Preferred apical distribution of glycosyl-phosphatidylinositol (GPI) anchored proteins: A highly conserved feature of the polarized epithelial cell phenotype The Journal of Membrane Biology. 113: 155-167. PMID 2138677 DOI: 10.1007/BF01872889  1
1989 Lisanti MP, Le Bivic A, Sargiacomo M, Rodriguez-Boulan E. Steady-state distribution and biogenesis of endogenous Madin-Darby canine kidney glycoproteins: Evidence for intracellular sorting and polarized cell surface delivery Journal of Cell Biology. 109: 2117-2127. PMID 2808522  1
1989 Lisanti MP, Darnell JC, Chan BL, Rodriguez-Boulan E, Saltiel AR. The distribution of glycosyl-phosphatidylinositol anchored proteins is differentially regulated by serum and insulin Biochemical and Biophysical Research Communications. 164: 824-832. PMID 2530980 DOI: 10.1016/0006-291X(89)91533-7  1
1989 Lisanti MP, Caras IW, Davitz MA, Rodriguez-Boulan E. A glycophospholipid membrane anchor acts as an apical targeting signal in polarized epithelial cells Journal of Cell Biology. 109: 2145-2156. PMID 2478564  1
1988 Lisanti MP, Sargiacomo M, Graeve L, Saltiel AR, Rodriguez-Boulan E. Polarized apical distribution of glycosyl-phosphatidylinositol-anchored proteins in a renal epithelial cell line Proceedings of the National Academy of Sciences of the United States of America. 85: 9557-9561. PMID 2974157  1
1988 Chan BL, Lisanti MP, Rodriguez-Boulan E, Saltiel AR. Insulin-stimulated release of lipoprotein lipase by metabolism of its phosphatidylinositol anchor Science. 241: 1670-1672. PMID 2843987  1
1985 Lisanti MP, Puszkin S. Mathematical modelling of the formation of coated vesicles. A theoretical geometrical approach Biochemical Journal. 230: 411-421. PMID 2864921  1
1984 Lisanti MP, Flanagan M, Puszkin S. Clathrin lattice reorganization: theoretical considerations Journal of Theoretical Biology. 108: 143-157. PMID 6431196 DOI: 10.1016/S0022-5193(84)80175-7  1
1983 Lisanti MP, Andrés A, Puszkin AC, Ores C, Schook WJ, Puszkin S. Immunocytochemical characterization of clathrin-associated proteins (CAPs) - II. Immunolocalization of CAPs using selectively-absorbed IgG solutions Cell and Tissue Research. 231: 507-518. PMID 6191865 DOI: 10.1007/BF00218109  1
1983 Puszkin S, Andres A, Ores C, Lisanti MP, Schook WJ. Immunocytochemical characterization of clathrin-associated proteins (CAPs) - I. Neuronal distribution of CAPs, a component of clathrin-coated vesicles Cell and Tissue Research. 231: 495-505. PMID 6135509 DOI: 10.1007/BF00218108  1
1982 Lisanti MP, Shapiro LS, Moskowitz N, Hua EL, Puszkin S, Schook W. Isolation and preliminary characterization of clathrin-associated proteins European Journal of Biochemistry. 125: 463-470. PMID 7117245  1
1982 Lisanti MP, Schook W, Moskowitz N, Ores C, Puszkin S. Brain clathrin and clathrin-associated proteins Biochemical Journal. 201: 297-304. PMID 7082291  1
Show low-probability matches.